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Cell-To-Cell Heterogeneity In Transcription And Splicing 
Abstract 
Biological variability is often treated as a drawback of biological systems, but we have used it to learn 
about various biological phenomena, such as mesenchymal stem cell variability and the timing of 
splicing. We quantified the variability of mesenchymal stem cell clones with respect to their ability to 
generate cartilage-like extracellular matrix tissues and used this variability to identify markers that could 
be used to sort cells that produce high quality cartilage tissue. This revealed that canonical markers 
commonly used in cartilage tissue engineering are poor markers of high performing mesenchymal stem 
cells, suggesting that sorting cells based on these markers will not enrich populations for cartilage tissue 
production. We also used RNA FISH to characterize single-cell level expression of these markers and 
found that the expression showed high variability and very little cell-to-cell memory. RNA FISH also 
revealed that during de-differentiation of chondrocytes in monolayer culture, expression of canonical 
markers does not decrease on the absolute level, but only relative to cell size, also suggesting the gene 
expression level of these markers is not the sole determining factor for the production of high-quality 
cartilage tissue. 
I then decided to use RNA FISH to quantify the gene-to-gene and intron-to-intron heterogeneity in splicing 
that occurs at and near the site of transcription, revealing a spectrum of co- and post-transcriptional 
splicing of endogenous genes. Observing multiple introns of the same gene simultaneously showed that 
introns are largely spliced independently of one another and not in a 5’ to 3’ order. Using a combination of 
RNA FISH and expansion microscopy, I show that transcripts dwell at the transcription site after 
transcription is complete, suggesting that fractionation methods may underestimate “post- 
transcriptionality”. Taken together, our observations suggest a model of dwell time at the site of 
transcription, variable intron retention, and a sequence-specific regulation of the timing and localization of 




Doctor of Philosophy (PhD) 
Graduate Group 




cartilage tissue engineering, RNA FISH, splicing, transcription 
Subject Categories 
Biology | Cell Biology | Molecular Biology 
This dissertation is available at ScholarlyCommons: https://repository.upenn.edu/edissertations/4052 
CELL-TO-CELL HETEROGENEITY IN TRANSCRIPTION AND SPLICING 
Allison Jean Cote 
A DISSERTATION 
in 
Cellular and Molecular Biology 
Presented to the Faculties of the University of Pennsylvania 
in 
Partial Fulfillment of the Requirements for the 
Degree of Doctor of Philosophy 
2020 
ring and Genetics 
Graduate Group Chairperson 
Daniel S. Kessler, Ph.D. 
Associate Professor of Cell and Developmental Biology 
Dissertation Committee: 
Jennifer E. Phillips-Cremins, Ph.D. 
Assistant Professor of Bioengineering 
Robert L. Mauck, Ph.D. 
Mary Black Ralston Professor of Orthopaedic Surgery, Professor of Bioengineering 
Rebecca G. Wells, M.D. 
Professor of Medicine, Bioengineering, and Pathology & Laboratory Medicine 
Christopher J. Lengner, Ph.D. 




I would like to thank my parents, for their endless love and support during my many 
years as a graduate student. 
 
I would like to thank John for his help and support over the past year, I would not have 
gotten through this without him. 
 
I discovered during my time as a graduate student that I have a vast support network 
and would like to thank all of my friends and family for supporting me through the many 
tough years. 
 
Lastly, I would like to thank Arjun, who never gave up on me. You have been an 
invaluable source of support and scientific guidance and will have a lasting impact on 
how I think and communicate with others. 
  
ABSTRACT
CELL-TO-CELL HETEROGENEITY IN TRANSCRIPTION AND SPLICING 
Allison Jean Coté 
Arjun Raj, Ph.D. 
Biological variability is often treated as a drawback of biological systems, but we have 
used it to learn about various biological phenomena, such as mesenchymal stem cell 
variability and the timing of splicing. We quantified the variability of mesenchymal stem 
cell clones with respect to their ability to generate cartilage-like extracellular matrix tissues 
and used this variability to identify markers that could be used to sort cells that produce 
high quality cartilage tissue. This revealed that canonical markers commonly used in 
cartilage tissue engineering are poor markers of high performing mesenchymal stem cells, 
suggesting that sorting cells based on these markers will not enrich populations for 
cartilage tissue production. We also used RNA FISH to characterize single-cell level 
expression of these markers and found that the expression showed high variability and 
very little cell-to-cell memory. RNA FISH also revealed that during de-differentiation of 
chondrocytes in monolayer culture, expression of canonical markers does not decrease 
on the absolute level, but only relative to cell size, also suggesting the gene expression 
level of these markers is not the sole determining factor for the production of high-quality 
cartilage tissue. 
I then decided to use RNA FISH to quantify the gene-to-gene and intron-to-intron 
heterogeneity in splicing that occurs at and near the site of transcription, revealing a 
spectrum of co- and post-transcriptional splicing of endogenous genes. Observing multiple 
introns of the same gene simultaneously showed that introns are largely spliced 
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independently of one another and not in a 5’ to 3’ order.  Using a combination of RNA 
FISH and expansion microscopy, I show that transcripts dwell at the transcription site after 
transcription is complete, suggesting that fractionation methods may underestimate “post-
transcriptionality”. Taken together, our observations suggest a model of dwell time at the 
site of transcription, variable intron retention, and a sequence-specific regulation of the 
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Chapter 1: Introduction 
Why are some cells different from others? Cells can differ from one another in many 
ways. A liver cell, for example, is different in many ways from a red blood cell. Even in the 
case of bacteria, there is variability from one cell to the next. This variability can be 
expressed through protein, RNA, DNA, sugars, lipids, ions, water, or any other type of 
molecule in the cell. Each type of variability has different consequences for cell function. 
Between cell types there are often obvious differences in cellular function, but these 
differences are frequently overlooked within seemingly identical cell populations. Many 
bulk assays obscure these differences by taking averages across thousands or millions of 
cells. Traditional gene expression assays, like microarrays or bulk RNA-sequencing, take 
averages across thousands of cells, even though there is marked heterogeneity in gene 
expression at the single cell level (Cote et al., 2016; Maamar et al., 2007; Raj et al., 2008, 
2006; Raj and van Oudenaarden, 2009; Tang et al., 2009).  
Gene expression can be regulated at many levels, from structural organization of the 
DNA to post-translational modifications of proteins. With the advent of high throughput 
sequencing technologies much focus has been placed on gene expression at the RNA 
level. Sequencing and imaging are now routinely applied at the single-cell level to 
characterize gene expression (Femino et al., 1998; Hwang et al., 2018; Raj et al., 2006; 
Stuart and Satija, 2019; Tang et al., 2009). Sequencing has been used to quantify many 
aspects of RNA expression variability, from the transcription of nascent RNA to RNA half-
life and degradation (Lugowski et al., 2018; Mayer et al., 2015). These sequencing 
methods can also yield information about intermediates of RNA processing, such as 
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splicing, capping, polyadenylation, editing, and modifications (Gruber et al., 2016; Motorin 
and Helm, 2019; Ramaswami et al., 2013; Takahashi et al., 2012; Waks et al., 2011).  
Other techniques, such as mass spectrometry to look at protein level heterogeneity, 
are still nascent in their application to single-cells (Budnik et al., 2018), but are areas of 
fervent development. All single cell techniques have revealed cell-to-cell heterogeneity in 
their respective measurements. Traditionally, it was assumed that cell-to-cell differences 
were due to genetic differences or differences in environment. However, single cell 
sequencing and imaging has revealed a variety of gene expression states at the RNA 
level, even within seemingly identical populations of cells (Symmons and Raj, 2016). This 
heterogeneity makes results from bulk assays hard to interpret and suggests that there is 
some underlying reason why genetically identical and environmentally similar cells have 
differences in gene expression.  
Many researchers, in a variety of contexts, have suggested that this heterogeneity in 
seemingly identical cells could be due to transient changes in gene expression (for a 
review, see (Raj and van Oudenaarden, 2008; Symmons and Raj, 2016)). These transient 
changes in gene expression have resulted in distinct phenotypes for these cells, such as 
drug resistance (Shaffer et al., 2017). However, this phenotype (drug resistance) was only 
possible with the transition of this transient state to a more permanent, heritable state of 
gene expression (Shaffer et al., 2017). Heritability, or the ability of a cell to “remember” its 
molecular state and recapitulate a similar state after the disruptive process of cell division, 
is especially important to consider in cases where cells can be separated by their gene 
expression state and then left to grow over time. In a case where gene expression was 
not heritable, cells isolated based on their expression of a particular gene (which is an 
extremely frequent method for isolating various cell types) could, soon after isolation, 
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express a completely different level of that gene. This lack of heritability could be one 
explanation for the high level of variability within a population of cells that was seemingly 
identical at a point in time. 
In this thesis, I have measured this heterogeneity in gene expression at two distinct 
regulatory steps in two different systems: 
1) Transcriptional heterogeneity in mesenchymal stem cells and chondrocytes 
2) Splicing heterogeneity in cancer cells 
I used this cell-to-cell heterogeneity in transcription and splicing to answer fundamental 
questions about the memory of transcription, predicting mesenchymal stem cell function, 
and the timing and spatial distributions of splicing.  
Heterogeneity of mesenchymal stem cells makes cartilage tissue 
engineered constructs inconsistent 
 
Cartilage degradation affects millions of people each year, causing a great deal of pain 
and loss of mobility (Chubinskaya et al., 2015). This degradation can be the result of many 
factors, such as age, BMI, joint stress, osteoarthritis, etc., but one universal result is an 
inability of cartilage to repair itself. Articular cartilage (a smooth, white cartilage found in 
joints) is frequently damaged by injury or by repetitive stresses from normal motions, such 
as walking (Chubinskaya et al., 2015; Coleman et al., 2017).  Several joints, particularly 
those in the knees, are under constant mechanical stresses even within the realm of 
normal motion. These mechanical stresses can damage and wear away the cartilage over 
time, forcing the loss of lubrication of joints that cartilage provides. 
It is difficult for cartilage to repair itself for two primary reasons: 1) cartilage is highly 
acellular, primarily consisting of extracellular matrix and 2) cartilage is highly avascular, 
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which prevents access to the necessary nutrients that might otherwise be needed for 
repair (Carballo et al., 2017; Sophia Fox et al., 2009; Woo and Buckwalter, 1988). The 
lack of cells in cartilage means that, once some cartilage is worn away, there are often 
very few cells nearby to replenish the extracellular matrix. For these reasons, researchers 
have turned to cartilage tissue engineering for repair of cartilage defects.  
The ultimate goal of cartilage tissue engineering is to create cartilage that can replace 
degraded cartilage tissue in vivo. To that end, researchers have turned to a combination 
of cells, scaffolding, soluble cues (such as cytokine treatment), and mechanical stresses 
to recreate cartilage in vitro (Huang et al., 2016; Rai et al., 2017). Each one of these factors 
can be manipulated individually or in combination to achieve cartilage like substances that 
are candidates for implantation to repair cartilage tissue, but it remains difficult to 
successfully reproduce cartilage substitutes with the same composition and mechanical 
qualities of native human cartilage .  
One of the many difficulties in reproducing cartilage is derived from the fact that cartilage, 
unlike many other tissues, is highly acellular, with chondrocytes (the primary - often 
considered only - cell type in cartilage) comprising only ~2% of cartilage volume  (Alford 
and Cole, 2005). Chondrocytes play an important role in local repair of cartilage substrate, 
but they are trapped by the vast extracellular matrix, comprising the majority of cartilage 
tissue volume (Sophia Fox et al., 2009). This extracellular matrix is comprised of primarily 
water (~80% of tissue volume) but this water is contained by a series of structural proteins 
(primarily type II collagen) and other macromolecules, primarily proteoglycans (Maroudas 
et al., 1991). Briefly, collagen is a structural protein that allows articular cartilage to resist 
tensile stresses and proteoglycans are protein molecules bound to glycosaminoglycans 
(sugars), which allow articular cartilage to resist compressive stresses. It is these 
 5 
extracellular matrix components that are frequently measured to determine success at in 
vitro cartilage formation, and are therefore traditionally used as chondrocyte “markers” 
(Mackay et al., 1998; Pittenger et al., 1999).  
Researchers have naturally turned to cartilage development to attempt to determine how 
to produce cartilage similar to in vivo human cartilage. The earliest stages of cartilage 
development involve condensation of mesenchymal cells and transient upregulation and 
deposition of certain extracellular matrix genes (DeLise et al., 2000). Then cells begin 
depositing specific extracellular matrix components that make up the final cartilage 
extracellular matrix (DeLise et al., 2000). Researchers have attempted to mimic this cell 
condensation with pellet based mesenchymal stem cell culture (Bosnakovski et al., 2006). 
In addition, cues of all types have been taken from cartilage development, such as a soft 
(compared to bone) substrate for cells (similar to that found in the cell condensation stage 
of cartilage development), TGF-β signaling, and mechanical stresses (DeLise et al., 2000; 
Mauck et al., 2006, 2000; Miura et al., 1994).  
Many substrates have been used to seed cells for cartilage tissue engineering, from 
hydrogels to actual decellularized cartilage matrix (Drury and Mooney, 2003; Rai et al., 
2017; Schwarz et al., 2012). These matrices span dimensions, from 2D to 3D, and even 
matrices that change over time (Liao et al., 2015; Panadero et al., 2016; Yoshimoto et al., 
2003). Hydrogels are popular scaffolds for cartilage tissue engineering (Drury and 
Mooney, 2003) because they can mimic the natural composition of cartilage, including 
collagen type II and glycosaminoglycans. One popular substrate for cartilage tissue 
engineering is agarose, a relatively soft hydrogel that supports chondrogenic matrix 
deposition while encapsulating the cells in a physiologically 3D environment (Benya and 
Shaffer, 1982; Mauck et al., 2006, 2000).  
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In addition to various physical cues that the substrate provides, cartilage tissue 
engineering also frequently employs soluble cues to encourage cartilage differentiation of 
the cells within the matrix and deposition of additional extracellular matrix components 
(Puetzer et al., 2010). One common soluble cue given to cartilage tissue engineering 
constructs is TGF-β, a cytokine implicated in cartilage tissue development (DeLise et al., 
2000; Miura et al., 1994; Puetzer et al., 2010; Wang et al., 2014). TGF-β is implicated in 
all stages of cartilage creation, from the initial mesenchymal cell condensation to 
maintenance of adult articular cartilage (Wang et al., 2014).  
TGF-β and a soft 3D matrix can both combine to encourage deposition of extracellular 
matrix components essential for cartilage function, such as collagen type II and 
glycosaminoglycans. However, the choice of cells to receive these soluble and physical 
cues remains of utmost importance. Many cell types have been used in cartilage tissue 
engineering, such as adult and juvenile chondrocytes, mesenchymal stem cells (the cell 
type that differentiates into chondrocytes during development), embryonic stem cells, and 
induced pluripotent stem cells (Benya and Shaffer, 1982; Castro-Viñuelas et al., 2018; 
Colter et al., 2001; Huang et al., 2010; Toh et al., 2011; Toh and Cao, 2014). However, 
each cell type comes with drawbacks. For example, chondrocytes have limited 
proliferative capacity and often begin to lose expression of essential genes over time in 
culture after their initial isolation (Darling and Athanasiou, 2005; Lin et al., 2008; Ma et al., 
2013). Mesenchymal stem cells, as well as embryonic and induced pluripotent stem cells, 
all need to be differentiated into a chondrocyte like cell before they begin depositing 
cartilage matrix proteins. However, mesenchymal stem cells are much further along the 
differentiation path to chondrocytes than either embryonic or induced pluripotent stem 
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cells, and therefore frequently exhibit greater matrix deposition in response to similar 
stimuli (Beane and Darling, 2012).  
However, even within the population termed “mesenchymal stem cells” there are many 
sources of heterogeneity. Mesenchymal stem cells are defined as cells that stick to plastic, 
express a particular set of markers (CD105, CD73 and CD90, and lack CD45, CD34, 
CD14 or CD11b, CD79alpha or CD19 and HLA-DR), and have the capacity to differentiate 
into osteoblasts, adipocytes and chondroblasts (Dominici et al., 2006). However, even 
within these exclusively selected cells there is heterogeneity (McLeod and Mauck, 2017). 
Mesenchymal stem cells can be isolated from many tissue locations, including bone 
marrow, adipose tissue, dental tissue, and many others, and each isolation location can 
yield mesenchymal stem cells of varying proliferative and matrix deposition capacity (Ng 
et al., 2016). Mesenchymal stem cells can also be isolated from a variety of different 
species, and each results in cartilage tissue constructs with varying properties (Sakata et 
al., 2015). Mouse cartilage, for example, is much more densely cellular than human 
cartilage (Stockwell, 1971), and therefore the properties of mesenchymal stem cells that 
form this cartilage are likely to be quite different. In a direct comparison of rat and human 
bone marrow derived mesenchymal stem cells, it was shown that rat mesenchymal stem 
cells can exhibit increased cartilage like matrix deposition as compared to human 
mesenchymal stem cells (Scuteri et al., 2014), suggesting that rat and mouse cells may 
not accurately model human cell behavior in this context. For this reason, many 
researchers have turned to isolating mesenchymal stem cells from larger animals with 
cartilage and cartilage defects more similar to human cartilage (Stockwell, 1971), such as 
cows (Mauck et al., 2006).  
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In addition to variation due to the location of isolation or cell species, the context of the 
specific donor of mesenchymal stem cells also matters (Phinney et al., 1999), especially 
in terms of donor age (D’Ippolito et al., 1999). However, even clonal populations (derived 
from single cells and therefore necessarily of the same isolation location, species, and 
donor) of mesenchymal stem cells exhibit varying capacity to differentiate into 
chondrocytes and other lineages (Muraglia et al., 2000; Russell et al., 2010). This 
suggests that there are necessarily non-genetic mechanisms that contribute to 
mesenchymal stem cell differentiation heterogeneity, and sequencing of naïve 
mesenchymal stem cells has shown that even without differentiation cues, clonal 
mesenchymal stem cells display heterogeneity in their transcriptomes (Delorme et al., 
2009; Freeman et al., 2015). This heterogeneity is apparently especially with regards to 
markers that may suggest differentiation of cells towards a particular phenotype, or lineage 
“priming” (Delorme et al., 2009; Freeman et al., 2015). These markers used to define 
phenotype or priming are often the markers of cartilage tissue itself, such as collagen type 
II (Delorme et al., 2009) or the transcription factors directly upstream of the markers of 
cartilage tissue differentiation, such as SOX9 (Freeman et al., 2015). These markers 
display marked heterogeneity in both the naive and differentiated mesenchymal stem cell 
populations (Cote et al., 2016; Delorme et al., 2009; Freeman et al., 2015). That begs the 
question, what does being a “marker” or a specific subpopulation really mean? Does that 
mean constant expression in that particular cell type and no expression in other cell types? 
If so, this suggests that traditional extracellular matrix associated gene expression is a 
poor marker of chondrogenic mesenchymal stem cells. 
In this thesis, I measured the cell-to-cell variability in gene expression of mesenchymal 
stem cells and chondrocytes using RNA FISH and RNA sequencing. RNA FISH is a 
 9 
technique that allows for visualization of individual mRNA in single cells (Femino et al., 
1998; Raj et al., 2006), and therefore let me identify gene expression signatures that 
suggested lineage priming in specific subsets of mesenchymal stem cells. I then used this 
lineage priming phenomenon to attempt to identify mesenchymal stem cells that would 
ultimately form the most cartilage extracellular matrix. I showed that canonical cartilage 
tissue markers are NOT good predictors of ultimate mesenchymal stem cell function, and 
that absolute RNA expression of these markers were also not a good indicator of 
chondrocyte dedifferentiation. A combination of RNA FISH and timelapse imaging showed 
that there is very little transcriptional memory of canonical cartilage tissue markers in 
mesenchymal stem cells, which may explain why they did not function as good a priori 
identifiers of high functioning mesenchymal stem cells.  
Fractionation and imaging yield conflicting information about the 
timing of splicing 
The life of an RNA begins at transcription and ends at degradation, with many potential 
regulatory steps in between (such as capping, polyadenylation, modifications, editing, 
splicing, nuclear export, translation, etc.). Each step has been extensively characterized 
using high throughput sequencing, among other methods (Gruber et al., 2016; Ingolia, 
2016; Motorin and Helm, 2019; Ramaswami et al., 2013; Stewart, 2019; Takahashi et al., 
2012; Valencia et al., 2008). One step in particular, splicing, has been shown to not only 
be an essential process for the majority of eukaryotic genes (Faustino and Cooper, 2003), 
but the discovery of alternative splicing has made it clear that splicing is also essential for 
creating the proteasomal diversity that is required by complex human development and 
function (Wang et al., 2015).  
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Splicing is the process by which precursor messenger RNA (pre-mRNA) becomes 
mature mRNA, via the excision of long, non-protein-coding regions of RNA (introns) from 
the rest of the RNA that will ultimately be translated into protein (exons). Splicing is an 
essential process in all eukaryotes and defects in both constitutive and alternative splicing 
cause a wide array of human diseases (Faustino and Cooper, 2003). Splicing is not only 
responsible for the removal of introns, but is also associated with various other RNA 
processing and quality control steps, such as nuclear export (Valencia et al., 2008). 
Alternative splicing is also important for eukaryotic development (Baralle and Giudice, 
2017), and over 95% of genes have been shown to be alternatively spliced in human cells 
(Pan et al., 2008).  
Though splicing has been shown to be an essential process for eukaryotic life (Faustino 
and Cooper, 2003), it is still unclear exactly when splicing happens. When the timing of 
splicing is altered, for example by the S34F mutation in the gene U2AF1, a core member 
of the spliceosomal machinery, it can result in alternative splicing and a drastic delay in 
the timing of splicing (Coulon et al., 2014). The S34F mutation in U2AF1 is frequently 
found in a variety of cancers as well (Kim et al., 2018; Palangat et al., 2019). Different 
types of measurements and measurements from different genes yield results that vary 
several orders of magnitude (Alpert et al., 2016). Different species also have drastically 
different gene structures, suggesting that conclusions from one may not be applicable to 
another (Keren et al., 2010). Yeast, for example, have short introns that are thought to be 
spliced out almost instantly (within a few seconds) after the process of transcription is 
completed (Wallace and Beggs, 2017). In species with much longer introns, such as 
humans and mice, splicing has been shown to potentially take much longer, with 
measurements ranging from 15 seconds up to 5-10 minutes (Alpert et al., 2016).  
 11 
Generally, the timing of splicing is broken down into two categories that compare splicing 
rate with the rates of other processing steps. These categories are “co-transcriptional” or 
tracking along with the polymerase as it transcribes, and “post-transcriptional”, or taking 
place after the process of transcription (and often polyadenylation as a surrogate for the 
end of transcription) has been completed. The dominant view of the field is that splicing 
happens primarily co-transcriptionally (Ameur et al., 2011; Bentley, 2014; Brugiolo et al., 
2013; Custódio and Carmo-Fonseca, 2016; Davis-Turak et al., 2015; Gazzoli et al., 2016; 
Goldstrohm et al., 2001; Herzel et al., 2017; Morlando et al., 2008; Nojima et al., 2018; 
Pandya-Jones and Black, 2009; Saldi et al., 2016; Singh and Padgett, 2009; Tilgner et al., 
2012). However, for many reporters and endogenous genes it has been shown that 
splicing is happening post-transcriptionally (Coulon et al., 2014; Vargas et al., 2011; Waks 
et al., 2011). Changing the timing of splicing by changing the elongation rate of RNA 
polymerase can cause drastic changes in alternative splicing in vivo (de la Mata et al., 
2003). Changing the timing of splicing via the S34F mutation in splicing factor U2AF1 can 
make splicing more “post-transcriptional” (Coulon et al., 2014).  
The timing of splicing has been shown to be important in many cases, but especially in 
cases of alternative splicing of certain genes (Waks et al., 2011). In cases where an RNA 
has many alternate isoforms, it could be necessary for the cell to completely synthesize 
the RNA before making its splicing “choice”. Thus, any splicing in that case would be 
completely post-transcriptional.  
The debate about the timing of splicing has been occurring for decades (Beyer et al., 
1981; Tsai et al., 1980). Some of the first evidence for co-transcriptional splicing came 
from EM images of Drosophila chromosomes spreads, which revealed nascent RNA still 
attached to chromatin being spliced (Beyer et al., 1981). The first evidence for post-
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transcriptional splicing came around the same time, when Tsai et al. observed high 
molecular weight poly-adenylated transcripts, which they suggested were unspliced, but 
fully transcribed, intermediates (Tsai et al., 1980).  
Currently, there are many methods by which researchers attempt to pinpoint the timing 
of splicing. Current imaging based methods include cyro-EM, live cell imaging of 
fluorescent reporter constructs, and RNA FISH of intronic and exonic sequences 
simultaneously (Coulon et al., 2014; Martin et al., 2013; Vargas et al., 2011; Waks et al., 
2011; Wilkinson et al., 2018). These methods all have the potential to reveal different 
information about the timing of splicing. Cyro-EM has been primarily used to identify the 
structures, and changes to those structures, that are essential for the splicing process 
(Wilkinson et al., 2018). Live cell imaging has been used to directly visualize the timing of 
splicing occurring in single, living cells, but this has primarily been for reporter constructs 
and modified endogenous genes (Coulon et al., 2014; Martin et al., 2013). RNA FISH has 
been used to show that splicing primarily happens at the site of transcription, but 
alternative splicing or insertion of polypyrimidine tract can spatially decouple transcription 
and splicing (Vargas et al., 2011; Waks et al., 2011; Zhang et al., 1994). Though imaging 
has yielded a great deal of information about the structure and timing of splicing 
intermediates, the primary ways by which the timing of splicing are characterized are 
fractionation and sequencing (or qPCR) based methods (Alexander et al., 2010a, 2010b; 
Carrillo Oesterreich et al., 2016, 2010; Churchman and Weissman, 2011; Harlen et al., 
2016; Milligan et al., 2016; Pandya-Jones and Black, 2009).  
There are many current fractionation based methods that have classified splicing as “co-
transcriptional” based on measuring the splicing status of RNA after different methods of 
isolating nascent RNAs. Chromatin fractionation is a popular method of isolating nascent 
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RNAs, whereby cells are separated into cytoplasmic, nucleoplasmic, and chromatin 
fractions (Tilgner et al., 2012). This separation is traditionally achieved by a series of 
increasingly harsh detergent concentrations, which lyse the cytoplasm first, allowing 
nuclear isolation, then lyse the nucleus and isolate chromatin by sedimentation via 
centrifugation (Mayer et al., 2015). Nojima et al. and others isolate nascent RNA by 
immunoprecipitating polymerase II and sequencing the RNA that is directly associated 
with various post-translational modifications of polymerase II (Harlen et al., 2016; Harlen 
and Churchman, 2017; Nojima et al., 2015). Nascent RNA can also be purified through 
various metabolic labelling techniques, in which a isolatable nucleotide analogue is 
incorporated into RNA being produced during a short period of time, and then RNA 
species with the metabolic label are isolated and their splicing status is measured (Barrass 
et al., 2015; Eser et al., 2016; Rabani et al., 2014, 2011; Windhager et al., 2012). All of 
these methods have suggested, thus far, that splicing largely happens immediately after 
the process of transcription, based on the presence of spliced RNA in the “nascent RNA” 
fractions. However, new methods that combine both metabolic labelling and chromatin 
fractionation are beginning to suggest that the presence of spliced RNA in the nascent 
RNA fractions may represent contamination of already transcribed, fully processed mRNA, 
and that, when the two methods of 4sU and chromatin isolation are combined, it reveals 
a much more “post-transcriptional” view of human splicing (Drexler et al., 2019).  
Though sequencing methods are now frequently applied at the single-cell level, 
information about the timing of splicing at the single-cell level is rare, with the notable 
exception of imaging based methods (Coulon et al., 2014; Martin et al., 2013; Vargas et 
al., 2011; Waks et al., 2011). However, it is clear that alternative splicing plays a large role 
in development, even at the single cell level (Lukacsovich et al., 2019; Tang et al., 2009), 
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and single cell sequencing methods have revealed a variety of splicing isoforms in single 
cells (Tang et al., 2009).  
In this thesis, I will characterize the single-cell level spatial distributions of splicing in 
various cancer cell lines using RNA FISH. I use this information to infer information about 
the timing of splicing within these individual cells, including showing that at least some 
splicing of each observed gene is happening post-transcriptionally. I also employ a 
combination of RNA FISH and expansion microscopy (Chen et al., 2016, 2015) to visualize 
individual RNA at the site of transcription and use this to infer that transcripts are not 
tethered to the site of transcription, and that transcripts dwell at the site of transcription 
after the process of transcription is completed, complicating results from fractionation 
assays. Taken together, my data suggests a model of variable timing of splicing of 
individual introns and a dwell time of transcripts at the site of transcription. 
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Chapter 2: Matrix expression does not predict matrix deposition 
Introduction 
Regenerative medicine strategies such as tissue engineering combine advances in 
cell biology, biomaterials and medicine to restore tissue function. Some approaches utilize 
stem cells for regeneration. For example, researchers commonly use multipotent 
progenitor cells, including mesenchymal stem cells (MSCs), for tissue engineering due to 
their capacity to undergo either osteogenic, adipogenic or chondrogenic differentiation 
(Pittenger et al., 1999). However, even with the most effective differentiation protocols, 
individual MSCs demonstrate heterogeneity in their biophysical properties and in their 
ability to undergo lineage commitment(Colter et al., 2001; González-Cruz et al., 2012; 
Mareddy et al., 2007; Phinney, 2012), with some clonal subpopulations robustly 
committing to a differentiated fate while other clones fail to respond to differentiation cues 
(Muraglia et al., 2000; Phinney, 2012; Russell et al., 2010). Furthermore, in cases in which 
it seems as though all cells have differentiated based on bulk expression of a particular 
marker, individual cells within the population may continue to express markers of other 
lineages (Ponce et al., 2008; Song, 2004). Given that underperforming, alternatively 
performing or non-responsive subpopulations will hinder the performance of engineered 
tissues, this inherent MSC heterogeneity compromises therapeutic efficacy. As such, 
quantitative strategies to select ‘superior’ subpopulations a priori would improve 
translational potential.  
Despite the phenotypic heterogeneity in MSC populations, most papers that explore 
the molecular underpinnings of phenotype monitor differentiation via bulk assays of 
transcriptional state and protein synthesis averaged over an entire cell population. These 
ensemble measurements, by definition, mask population heterogeneity (Altschuler and 
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Wu, 2010; Nimmo et al., 2015). The advent of single-cell methods allows for the 
measurement of cell-to-cell variation and the ability to quantify absolute gene expression 
in a single cell (Crosetto et al., 2015; Itzkovitz and van Oudenaarden, 2011; Junker and 
van Oudenaarden, 2014), revealing, for example, marked transcriptional heterogeneity. 
Real-time fluorescent monitoring of changes in transcript levels in individual cells has also 
shown that individual MSCs differ in the timing and extent to which they upregulate an 
early osteogenic marker (Marble et al., 2014). These findings underscore the limitations 
of coarse ensemble approaches and highlight the need for single-cell molecular profiling 
of these differentiation events. Although it is reasonable to speculate that the 
subpopulation of cells expressing high levels of marker genes would ultimately be the 
most chondrogenic, this hypothesis remains untested.  
Given that individual MSCs are highly variable in their capacity to undergo 
chondrogenesis and accumulate cartilage-like matrix (Huang et al., 2010), we postulated 
that one could use single-cell marker gene transcript levels as a means to enrich for MSC 
subpopulations most suited for therapeutic application. Here we define this relationship by 
developing probe sets for RNA fluorescence in situ hybridization (FISH) directed against 
transcripts of markers of cartilage, bone and fat, and use single-cell analysis to delineate 
the relationships between absolute transcript level and differentiated cell function. 
Specifically, we hypothesized that cells that robustly accumulate an aggrecan-rich, 
cartilage-like matrix would also express high levels of aggrecan mRNA, while at the same 
time suppressing markers of other lineages.  
We find surprising levels of variability in the expression of aggrecan and other marker 
genes between individual MSCs both before and after differentiation. However, when we 
compare the expression with functional capacity (defined by actual matrix deposition) on 
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a single-cell basis, we find a weak correlation between transcript abundance and protein 
expression. Transcriptome-wide analysis via RNA sequencing further suggests that 
neither an expanded set of marker genes, nor the principal components of global gene 
expression variation, correlate strongly with functional capacity. Indeed, even in fully 
differentiated chondrocytes derived from native tissue, absolute aggrecan mRNA 
expression is decoupled from cartilage-like matrix accumulation. Collectively, these 
findings suggest that sorting based solely on a small set of differentiation markers will not 
improve chondrogenic outcomes, and challenge the traditional notion that marker gene 




Single cells express differentiation markers heterogeneously.  
To quantify absolute gene expression of marker genes on a single-cell basis during MSC 
differentiation and chondrocyte de-/re-differentiation, we paired classic cartilage tissue 
engineering and cartilage biology experiments with single-molecule RNA FISH (Femino 
et al., 1998; Raj et al., 2008). Specifically, we monitored the simultaneous expression of 
aggrecan as a marker of chondrogenic differentiation, GAPDH as a reference gene, and 
osteopontin and lipoprotein lipase (LPL) as markers of alternate fates (osteogenesis and 
adipogenesis, respectively) (Frank et al., 2002; Pelttari et al., 2008; Sekiya et al., 2003). 
For each gene, we designed fluorescently labelled sequence-specific oligonucleotide 
probes to visualize individual mRNA molecules in intact fixed cells. Individual mRNA 
appeared as bright diffraction limited spots (Fig. 1a,b), and subsequent spot counting 
yielded absolute copy number at the single-cell level.  
To show that our measurements corresponded well with existing measurements of these 
systems, we first determined how absolute gene expression changed as MSCs underwent 
chondrogenic differentiation. To do so, we formed engineered constructs and used RNA 
FISH to quantify gene expression over 3 weeks in chemically defined media with or without 
transforming growth factor-b (TGFb; chondrogenic induction media and control media, 
respectively, Fig. 1c). As expected, chondrogenic induction promoted proteoglycan 
synthesis and matrix accumulation (Fig. 1d) and increased aggrecan copy number in 
comparison with control media (Fig. 1e). Although there was considerable donor-to-donor 
variability in mean aggrecan levels and matrix deposition, the trends were similar between 
donors, with mean aggrecan copy number generally increasing over the first 7 days, 





















































































































































GAPDH copy number increased with exposure to induction media (Supplementary Fig. 
1b). Thus, in aggregate, this RNA FISH analysis aligned with the canonical understanding 
of gene expression changes during chondrogenic differentiation (Puetzer et al., 2010). 
While these ensemble measures corresponded with previous findings, they did not provide 
information on cell-to-cell variability in expression of these lineage markers. Thus, we 
measured mRNA copy number on a cell-by-cell basis under baseline conditions and with 
differentiation. We assayed four conditions: naive MSCs in expansion culture, MSCs 
differentiating in engineered constructs after 1 and 21 days in induction media, and as a 
positive control, fully differentiated primary chondrocytes (Fig. 1f,g). For each of these 
groups, single-cell analysis showed striking heterogeneity in expression, with aggrecan 
mRNA copy number per cell spanning three orders of magnitude (100–102). Consistent 
with the notion that stem cells exhibit greater variability than differentiated cells, naive 
MSCs showed the greatest heterogeneity in aggrecan expression (as measured by the 
coefficient of variation, Table 1), and the coefficient of variation decreased with exposure 
to induction media. However, the variability remained high even after long periods of time 
in differentiation culture (Fig. 1g). Fully differentiated chondrocytes had the most 
homogeneous aggrecan expression of all the cell types and conditions we examined, 
Figure 1 RNA FISH reveals heterogeneity in lineage marker expression in MSCSs and chondrocytes (a,b) 
Representative images (a) and schematic (b) of single-molecule RNA FISH, in which fluorescently labelled DNA 
oligonucleotides enable quantification of absolute expression of multiple genes in the same cell. Scale bar, 10 
mm. (c) Chondrogenic induction scheme, involving cell encapsulation in 3D agarose constructs and exposure to 
TGFb. (d) Alcian blue staining for sulfated proteoglycans; Donor B shown. Scale bar, 5 mm. (e) Mean aggrecan 
RNA counts in MSCs cultured in 3D for up to 21 days. Narrow bars represent the mean within an individual 
donor; overlaid bars represent the mean across donors. Error bars indicate standard error (n = 24–128 cells per 
donor and condition). Means compared by t-tests with Satterthwaite approximation and simulated adjustment for 
multiple comparisons, **P<0.01 versus TGFb conditions, and between þ TGFb time points. See Supplementary 
Table 4 for all statistical comparisons. (f,g) Distributions of single-cell aggrecan expression for chondrocytes and 
MSCs plated on glass in basal media (f, n = 56 chondrocytes, 49 MSCs) and 3D encapsulated MSCs exposed to 
TGFb for 1 and 21 days (g, n = 105 cells for day 1, 79 cells for day 21; Donor A shown.) (h) Single-cell aggrecan 
expression for each donor after 7 days of 3D culture with TGFb relative to the median aggrecan expression in 
freshly isolated chondrocytes (dashed line; n = 103 cells for Donor A, 54 cells for Donor B and 65 cells for Donor 
C). (i) Simultaneous expression of aggrecan, osteopontin, LPL and GAPDH on day 1 and day 21; Donor A 
shown (n = 105 cells for day 1, 79 cells for day 21).  
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though their mean aggrecan copy number was slightly lower than that of differentiated 
MSCs. These data show that MSCs exhibit substantial cell-to-cell expression 
heterogeneity and that, while chondrogenic culture promotes a chondrocyte-like gene 
expression pattern, copy number remains highly variable between cells. Indeed, this 
variability within a population of differentiated MSCs overshadowed differences in mean 
expression between donors (3–4 orders of magnitude versus a maximum of twofold 
difference, Fig. 1h). This heterogeneity may either reflect different subpopulations that 
have adopted distinct fates or appear in cells that remain uncommitted. In the former 
scenario, if differentiated MSCs can express markers for only one fate at a time, then 
alternate lineage commitment should manifest as an anti-correlation between aggrecan 
and other lineage markers at the single-cell level. To determine whether this was the case, 
we performed RNA FISH for aggrecan, osteopontin and LPL in the same cells, with the 
latter two markers indicating osteogenic and adipogenic lineages, respectively. Rather 
than identifying subpopulations that were distinctly chondrogenic or osteogenic, we 
instead observed a slight positive correlation between aggrecan and osteopontin (Fig. 1i, 
Day 1 r2 = 0.49, P < 0.001; Day 21 r2 = 0.34, P < 0.005). Conversely, LPL expression was 
minimal, and did not correlate with either aggrecan or osteopontin expression 
(Supplementary Table 2). These data suggested that heterogeneity in marker expression 
after differentiation is not due to alternate lineage commitment, but rather highlights the 
fact that even differentiated MSCs can express high levels of markers for inappropriate 
lineages. 
 
RNA levels poorly predict single-cell functional potential.  
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On the basis of this tremendous cell-to-cell heterogeneity in chondrogenic gene 
expression, we next asked whether aggrecan or other markers might serve as a means 
for separating robustly chondrogenic cells from the less chondrogenic ones in the initial 
heterogeneous population. For this to be possible, mRNA levels would need to correlate 
with chondrogenic capacity, indicated by the accumulation of a proteoglycan-rich 
extracellular matrix. To determine whether such a connection existed, we seeded MSCs 
in three-dimensional (3D) culture and induced chondrogenesis for 7 days, the point at 
which mean aggrecan expression peaked. We then performed immunofluorescent 
staining for aggrecan core protein (a central component of the cartilage-like extracellular 
matrix) simultaneously with RNA FISH using one of two probe sets: probes for markers of 
multiple fates (aggrecan, osteopontin, LPL and GAPDH; Batch 1 samples) or probes for 
chondrogenic markers (Sox9, cartilage oligomeric matrix protein (COMP) and GAPDH; 
Batch 2 samples). We designated cells with evidence of extracellular staining for aggrecan 
core protein as ‘high-performing’ (comprising 12–62% of the population, depending on 
donor), and cells lacking extracellular staining as ‘low-performing’ (Fig. 2a,b).  
Surprisingly, aggrecan expression did not strongly predict aggrecan core protein 
accumulation. Indeed, even within a single donor, the distribution of aggrecan mRNA 
abundance in high- and low-performing cells overlapped substantially (Fig. 2c). The 
mRNA/cell distributions of other chondrogenic markers (COMP, Sox9), markers of 
alternative fates (osteopontin, LPL) and the housekeeping gene GAPDH (Supplementary 
Fig. 2a) also demonstrated similar overlap. While in aggregate, the high-performing cells  
had a greater mean expression of aggrecan, COMP and Sox9, and lower mean 
expression of osteopontin than low-performing cells, the magnitude of these differences 
was small and similar to the shift seen in GAPDH expression (Supplementary Fig. 2a,  
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Table 1: Mean and Coefficient of Variation Associated with Aggrecan RNA 
Count in Undifferentiated and Differentiated Cells 
  Mean Aggrecan Aggrecan CV 
Naive MSCs 69 1.60 
Day 1 MSCs in gels 247 0.69 
Day 21 MSCs in gels 334 0.72 
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  Figure 2 | Marker gene expression is 
a poor predictor of cartilage-like 
matrix production in individual 
MSCs. (a) Aggrecan core protein 
identified by immunostaining of MSCs 
showing high or low cartilage-like 
matrix formation after 7 days of 3D 
culture with TGFb. Scale bar 1⁄4 10 
mm. 
(b) Fraction of cells classified as high- 
or low-performing based on aggrecan 
protein staining (cells/donor: D: 78, E: 
89, F: 51, X: 62, Y: 43, Z: 47). 
(c) Distribution of aggrecan copy 
number in high- and low-performing 
MSC populations; probability density 
curve for Donor E shown (n 1⁄4 153 
cells). (d,e) Receiver operating 
characteristic curves using individual 
gene expression and regression 
analysis on combinations of genes 
from batch 1 (d) and individual gene 
expression from batch 2 genes (e) to 
distinguish between high- and low-
performing MSCs (cells/donor: D: 132, 
E: 153, F: 122, X: 57, Y: 42, Z: 47). (f) 
Summary graph of area under the 
curve of receiver operating 
characteristic curves for individual 
gene expression, gene expression 
ratios, and regression analysis of 
combinations of gene. (g,h) Simulated 
sorting of MSCs into anticipated high- 
and low-performing cells, using the 
optimized threshold of 405 aggrecan 
mRNA copies (g) and the optimized 
threshold from the ACAN þ OPN 
regression (h). 
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aggrecan: 1.35-fold increase, COMP: 1.14-fold increase, Sox9: 1.33-fold increase, 
GAPDH: 1.17-fold increase, osteopontin: 1.22-fold decrease). We also determined the 
expression ratios relative to commonly used normalization genes (that is, 
aggrecan/GAPDH) or to genes indicating alternate lineage specification (that is, 
aggrecan/osteopontin). These metrics also showed substantial overlap and small effect 
size (Supplementary Fig. 2a). Thus on this qualitative basis, neither absolute nor 
normalized single-cell expression of marker genes was highly predictive of chondrogenic 
capacity at the single-cell level.  
To quantify the ability of transcript abundance to predict the extent of a cell’s matrix 
accumulation, and thus sort high- from low-performing cells, we constructed receiver 
operating characteristic (ROC) curves to determine the ‘true positive’ (sensitivity) and ‘true 
negative’ (specificity) rates associated with potential mRNA thresholds. We pooled data 
across donors assayed using the same probes (batches 1 and 2). Within each batch, we 
plotted the high/low classification performance of individual genes, gene expression ratios 
and linear combinations of gene expression levels (Fig. 2d–f, Supplementary Fig. 2b). 
While each metric discriminated between high- and low-performing cells better than 
random chance (represented by the diagonal line on the ROC plots, and an area under 
the curve > 0.5), the improvements in selection specificity were relatively small. Of the 
individual RNA types indicative of the chondrogenic lineage, aggrecan and Sox9 were 
best able to discriminate between high- and low-performing cells. For example, consider 
the optimized threshold of 405 aggrecan mRNA, which maximizes the Youden J statistic 
(sensitivity þ specificity 1). Conceptually, we can designate all cells with 4405 aggrecan 
RNA as anticipated high performers, and others as anticipated low performers. For the 
donors studied, this unsorted population was 34% high- and 66% low-performing cells.  
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Sorting based on this optimized aggrecan threshold misclassified 37% of all cells (that 
is, percent of high cells predicted to be low, or low cells predicted to be high). 50% of high-
performing cells were lost due to incorrect classification as ‘anticipated-low’ cells, and the 
fraction of high-performing cells in the ‘anticipated-high’ population was enriched only 35% 
over the unsorted population (Fig. 2g). A logistic regression model combining aggrecan 
and osteopontin expression improved on this performance only slightly, where its 
optimized threshold yielded a 33% misclassification rate, and enriched the fraction of high 
cells by 37% (Fig. 2h, versus 35% for aggrecan alone). Of the gene expression ratios, 
aggrecan/osteopontin was a better discriminator than aggrecan/GAPDH, though its 
selection performance did not surpass that of aggrecan alone. Sorting on a donor-by-
donor basis was similarly ineffective (Supplementary Fig. 2b). Thus, sorting cells based 
on expression of aggrecan, other common differentiation markers, and linear 
combinations thereof would result in only marginal enrichment of the population, while 
substantially reducing available cell number. 
 
Whole transcriptome profiling suggests few combinations of markers are predictive of 
functional potential 
 
On the basis of the inability of aggrecan and other lineage-specific markers to robustly 
predict matrix accumulation at the single-cell level, we next utilized high-throughput RNA 
sequencing to determine whether other features of the transcriptome, and specifically 
factors present in the undifferentiated population, might prospectively identify MSCs with 
high differentiation potential. We expanded single-cell-derived MSC colonies in monolayer 
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Figure 3 | Genome-wide transcriptome profiling does not predict MSC functional potential. (a) 
Schematic for RNA sequencing and testing of functional capacity of single-cell-derived clones. (b) 
Unbiased clustering of clones (and heterogeneous population) based on fragments per kilobase of 
transcript per million reads (FPKM) of RNA sequencing results (subsetted for genes where at least one 
sample had FPKM <1). (c) Glycosaminoglycan deposition per DNA in micropellets derived from clonal or 
heterogeneous populations (from part b) cultured for 21 days in chondrogenic (TGFb þ ) culture media.For 
clones with limited cell number, one pellet was formed and assayed (Clones M, F, K, P, Q, W, I). For 
clones with cell number sufficient for multiple pellets, error bars indicate standard deviation (3 pellets—Het 
and clones B, E, L, G, C, O, J, H; 2 pellets—clone D). (d) Principal component analysis of same RNA 
sequencing results as in part b, coloured by GAG/DNA for each clone. (e) Log2 transformed FPKM of 
selected genes from RNA sequencing results as a function of GAG/DNA for each clone. 
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analysis. The remaining fraction was expanded through an additional passage, formed 
into pellets and cultured in the presence of TGF-ß for 21 days to assay chondrogenic 
potential (Fig. 3a). This evaluation of baseline MSC gene expression in clonal populations 
derived from single cells had the potential to identify markers that could be used to sort 
freshly isolated MSCs based on their gene expression signatures. An initial comparison 
of differential expression between clones (Fig. 3b), as compared with the deposition of 
extracellular matrix components of each clone (Fig. 3c), revealed no striking patterns of 
gene expression that correlated with subsequent matrix deposition. We also used principal 
component analysis to determine whether the variation between the gene expression of 
each clone could be used to predict functional capacity, but there was no relationship 
between clustering in either of the first two principal components and matrix deposition 
(Fig. 3d). Given that the full transcriptome lacked global predictive capacity, we next 
sought to broaden our conclusions from the FISH experiments by examining the 
sequencing data associated with individual genes. We selected a small subset of genes 
that corresponded to four categories of markers identified in previous studies: 
chondrogenic markers, stemness markers, cell cycle-associated genes and housekeeping 
genes (Chan et al., 2015). Consistent with our single-cell analysis results, none of these 
genes correlated strongly with functional potential on a clonal basis (Fig. 3e). Even the 
most predictive genes, MMP13 and aggrecan, correlated only weakly (r2 = 0.3, P = <0.05 
and r2 = 0.23, P = 0.062, respectively). Altogether, this transcriptomic analysis suggests 
that there is no expression signature at the RNA level that could pre-identify specific clones 
with high chondrogenic potential. 
 29 
 
Marker heterogeneity emerges rapidly after cell division.  
 
On the basis of the inability of transcript levels to robustly predict matrix forming potential, 
we next asked whether it was propagated through cell division; that is, whether cells with 
a higher expression level would transmit this feature to their daughter cells. As an initial 
assay, we measured aggrecan copy number in every cell located within a series of small 
MSC colonies stimulated with TGFb (where each individual colony likely arose from a 
single cell, Fig. 4a). Results from this analysis showed that aggrecan copy number varied 
more within a single colony than it did between colonies (Fig. 4b). This result suggests 
that with just a few cell divisions, aggrecan levels rapidly devolved to recapitulate the 
heterogeneity present in the bulk population. In contrast, GAPDH was less variable than 
aggrecan within each colony (lower coefficient of variation, Supplementary Table 3), but 
showed greater differences in mean level between colonies (Fig. 4c). Thus, not every gene 
demonstrated the high intra-colony variability observed in aggrecan expression, and some 
genes were differentially expressed between colonies. However, without live cell time-
lapse measurements of the cellular lineage, it was difficult to directly show that variability 
in aggrecan mRNA levels arose through randomization rather than heritable differences. 
To overcome this limitation, we next continuously tracked MSCs as they migrated and 
divided in induction media by live cell microscopy for 3 days, and correlated terminal 
aggrecan expression between sister cells with respect to the time since their last division 
(Fig. 4d). Shortly after division (< 12 h), sister cells had comparable aggrecan and GAPDH 
levels (Fig. 4e,f, Supplementary Fig. 3a,b), suggesting symmetric partitioning of RNA. 
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Figure 4 | Marker expression heterogeneity emerges shortly after cell division. (a–c) Gene 
expression in small MSC colonies. (a) Colony formation scheme. (b,c) Aggrecan and GAPDH 
expression in four colonies established from a single donor (n 1⁄4 75 cells in colony A, 7 cells in 
colony B, 6 cells in colony C, 8 cells in colony D). (d) Live cell tracking scheme to identify sister cell 
pairs at various times post-cell division. (e,f) Divergence in aggrecan gene expression between sister 
cells as a function of time since last division (n 1⁄4 81 sister cell pairs). Box hinges denote the first 
and third quartiles. Whiskers extend from the hinges to the most extreme data points within (1.5 * 
interquartile range) of the hinges. Means compared by t-tests with Satterthwaite approximation and 
simulated adjustment for multiple comparisons, ***P<0.001, see Supplementary Table 5 for all 
comparisons. 
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 levels of aggrecan and GAPDH expression (Fig. 4e,f, Supplementary Fig. 3a,b, 
Supplementary Table 6). Within cell pairs, aggrecan and GAPDH divergence only weakly 
correlated, suggesting that the relative difference between sister cells was not globally 
regulated, underscoring the fact that aggrecan and GAPDH do not necessarily change 
together (Supplementary Fig. 3c,d). These findings may reflect a difference in cell function 
as a consequence of asymmetric cell division (that is, sister cells have different target 
expression levels) or could simply identify how asynchronous dynamic fluctuations lead to 
temporal differences in expression level. In either case, these differences suggest that a 
sorted population of high-aggrecan cells would not remain so for more than a couple of 
days, and may explain why, at the single-cell level, cells with high-aggrecan RNA 
expression are not necessarily the cells with the greatest amount of matrix deposition. 
 
Marker genes do not identify a chondrocyte phenotype.  
 
While aggrecan gene expression did not correlate with matrix deposition in MSCs, it is a 
canonical feature of the differentiated chondrocyte ‘phenotype’ and is widely considered 
to be a leading indicator of cartilage-specific extracellular matrix deposition (for example, 
aggrecan core protein) (Barry et al., 2001; Mackay et al., 1998; Vertel, 1995). It is also 
well accepted that, on serial passaging and expansion in monolayer, chondrocyte matrix 
production decreases along with a multi-fold decrease in the aggrecan/GAPDH ratio (Fig. 
5a) (Cheng et al., 2012; Darling and Athanasiou, 2005; Elima and Vuorio, 1989; Lin et al., 
2008; Ma et al., 2013). This change in expression is associated with increases in cell size 
and proliferation rate (Glowacki et al., 1983; Kumar and Lassar, 2009; Schiltz et al., 1973). 
To reconcile our finding of discordant aggrecan expression and matrix deposition in MSCs 
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RNA FISH on chondrocytes that were serially passaged in monolayer to induce ‘de-
differentiation’ and after subsequent ‘re-differentiated’ in 3D culture (where one would 
expect a resumption of the cartilage phenotype) (Benya and Shaffer, 1982; Bonaventure 
et al., 1994). For de-differentiation studies, we serially passaged chondrocytes nine times 
in monolayer with analysis at every other passage via RNA FISH. Consistent with classical 
findings (Benya and Shaffer, 1982; Stokes et al., 2001), the normalized ratio of aggrecan 
to GAPDH expression level decreased with passage number (Fig. 5b). However, and quite 
surprisingly, this change was not due to a decrease in absolute aggrecan copy number 
(Fig. 5c). Rather, aggrecan copy number showed a small but significant increase from 
passage 0 (initial plating) to passage 1, before returning to passage 0 mean copy number 
at later passages. In contrast, there was a rapid increase in mean GAPDH copy number 
over the first passage (increasing > fourfold) that remained at these elevated levels 
through additional passages (Fig. 5d). Previous studies from our group have shown that 
global transcription (including expression of GAPDH and many other abundant 
‘housekeeping’ genes) correlates with and can be dictated by cell size (Padovan-Merhar 
Figure 5 | Chondrocyte de- and re-differentiation are not driven by altered absolute aggrecan 
expression. (a) Chondrocyte de-differentiation and re-differentiation scheme. (b–f) Analysis of chondrocytes 
de-differentiating with passage in monolayer culture. (b) RNA FISH counts of aggrecan pooled over the 
population and normalized to GAPDH expression. (c) Absolute aggrecan expression with passage number. (d) 
Absolute GAPDH expression with passage number (n 1⁄4 39–113 cells per donor per passage). (e,f) 
Chondrocyte suspended cell volume (e) and morphology (f) with passage (n 1⁄4 274–543 cells per donor per 
passage). Scale bar, 50 mm. (g–j) Analyses of early passage (P0) and late passage (P5) chondrocytes re-
differentiating in 3D culture. (g) Alcian blue staining after 1 and 14 days of 3D culture. Top scale bar, 5 mm, 
bottom scale bar, 100 mm. (h) Absolute aggrecan expression. (i) Absolute GAPDH expression. (j) Single-cell 
aggrecan expression normalized to GAPDH expression. (n 1⁄4 46–65 cells per donor per condition). Narrow 
bars represent the mean within an individual donor; overlaid bars represent the mean across donors. Error bars 
indicate standard error. RNA count means compared by t-tests with Satterthwaite approximation and simulated 
adjustment for multiple comparisons. Pooled aggrecan/GAPDH expression data, cell area data, and cell volume 
data compared using a one-way analysis of variance with Tukey’s post-hoc test. *Po0.05, **Po0.01 and 
***Po0.001, see Supplementary Tables 7 and 8 for all comparisons. 
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et al., 2015). We also found that chondrocyte spread-cell area generally increased with 
passage number (Fig. 5f, Supplementary Fig. 4) and that the mean volume of suspended 
cells increased by > threefold between primary isolation (passage 0) and passage 5 (Fig. 
5e). Taken together, these findings suggest that aggrecan expression does not decrease 
with chondrocyte de-differentiation and does not correlate with chondrocyte functional 
potential at the population level. Instead, normalization to housekeeping genes obscures 
relatively minor changes in aggrecan gene expression that occurs during chondrocyte ‘de-
differentiation’. These single-cell data suggest that canonical markers of the chondrocyte 
phenotype do not accurately describe the molecular profile of de-differentiation. To further 
explore how normalization may confound our interpretation of gene expression changes, 
we forced the re-differentiation of culture-expanded chondrocytes that had lost their 
‘phenotype’. To do so, we encapsulated chondrocytes at early and late passage (passage 
0 and 5, respectively) in 3D agarose hydrogels, and monitored matrix synthesis and gene 
expression over 2 weeks via Alcian blue staining and RNA FISH (Fig. 5a). Consistent with 
classical studies (Benya and Shaffer, 1982; Bonaventure et al., 1994), early passage 
chondrocytes produced matrix robustly on encapsulation, while late passage (de-
differentiated) chondrocytes showed a significant attenuation in matrix deposition (Fig. 
5g). RNA FISH showed that after 1 day of agarose culture, late passage chondrocytes 
expressed more aggrecan and more GAPDH than early passage chondrocytes (Fig. 5h,i). 
Over 14 days, mean aggrecan levels were maintained in early passage cells, but 
decreased in late passage cells. In keeping with our findings in monolayer, the aggrecan/ 
GAPDH ratio was strongly influenced by changes in GAPDH (Fig. 5j). These data further 
support the finding that absolute changes in aggrecan expression levels are not 




In this work, quantitative single-cell analysis of gene expression provided evidence that 
the abundance of mRNA markers is only weakly linked to the chondrogenic phenotype of 
cartilage and progenitor cells. Specifically, we found that both MSCs and chondrocytes 
exhibited rampant transcriptional heterogeneity. This observation was not altogether 
surprising for MSCs, given that a single MSC population is comprised of a heterogeneous 
pool of related but distinct clonal populations. However, the transcriptional heterogeneity 
within individual MSC colonies suggested that this overall population heterogeneity is not 
entirely due to the mixing of clonal populations of varying potency, but instead likely arose 
from random transcriptional processes. While such heterogeneity may confound the 
interpretation of ensemble measurements, if this variation reflected intrinsic differences in 
differentiation capacity or differentiated state, then it might be harnessed towards a 
productive end. That is, cell sorting based on this variability could enable selection of 
‘superior' sub-populations for therapeutic applications. For example, the expression of 
‘stemness markers' such as SOX2 (Larsson et al., 2012), OCT4 (King et al., 2011) and 
NANOG (Lahm et al., 2015) can distinguish pluripotent cells from larger heterogeneous 
populations, and the expression of an early osteogenic marker enables enrichment of the 
stromal vascular fraction for osteogenic cells (Marble et al., 2014).  
However, our data show that for naive MSCs, neither genome-wide transcriptional 
metrics nor the transcriptional abundance of MSC stemness and chondrogenic markers 
correlate with the ultimate functional capacity. Strikingly, the most predictive genes 
(aggrecan and MMP13) were negatively associated with chondrogenic capacity, 
potentially suggesting that high-transcriptional promiscuity in naive MSCs reflects an 
inability to undergo robust lineage commitment. Furthermore, our single-cell studies 
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showed that while naive MSCs and chondrocytes represent opposite ends of the 
differentiation spectrum, their absolute expression of canonical differentiation markers 
largely overlapped. When we monitored gene expression and cartilage-like matrix 
accumulation simultaneously on a cell-by-cell basis, marker expression taken at a single 
time point only weakly associated with cell output of extracellular matrix. Thus, we 
conclude that marker expression would only enable a slight enrichment of the population 
(∼35% increase in high-performing cells over the unsorted population) while drastically 
restricting available cell number for therapeutic application. 
One possible explanation of the disconnect between an individual cell's transcript 
abundance and differentiated state is that, for many genes, transcription is a stochastic 
process comprised of long ‘silent' periods punctuated by short transcriptional bursts 
(Chubb et al., 2006; Golding et al., 2005; Raj et al., 2006; Raj and van Oudenaarden, 
2009; Suter et al., 2011; Zenklusen et al., 2008). Bursting kinetics are strongly dependent 
on both the gene in question and the stimulus that is applied (Dar et al., 2012; Octavio et 
al., 2009; Raj et al., 2006; Suter et al., 2011), along with the position in cell cycle and cell 
volume (Padovan-Merhar et al., 2015; Zopf et al., 2013). For instance, stimulation (for 
example, TGFβ) can induce a synchronized initial burst of target gene expression, but 
subsequent bursts are typically asynchronous (Cai et al., 2008; Gandhi et al., 2011; Molina 
et al., 2013; Shah and Tyagi, 2013). Thus, two cells with fluctuating but equivalent gene 
expression over time may exhibit different copy number when sampled at a single time 
point. As recently reported (Kumar et al., 2014; Molina et al., 2013), the rate of fluctuation 
(slow versus fast) of a single gene manifests in the heterogeneity observed between and 
within small clonal clusters. Our findings of high intra-colony variability and sister cell 
divergence in MSCs suggest that marker copy number fluctuates rapidly over a short 
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timescale. As a result, absolute marker gene expression is not strongly heritable in MSCs, 
and we speculate that cells sorted on the basis of such expression will undergo 
transcriptional shifts over time and with further population expansion. In other systems, 
such stochastic variation in gene expression not only marks but can also determine cell 
fate (Choi et al., 2008; Eldar and Elowitz, 2010; Maamar et al., 2007; Raj et al., 2010; Raj 
and van Oudenaarden, 2008; Süel et al., 2007; Wernet et al., 2006). Here it is surprising 
that for aggrecan, a gene whose product plays such a critical role in the extracellular 
matrix, such emergent heterogeneity in transcript abundance does not appear to reflect 
true variation in potency. 
The disconnect between expression and functional capacity (matrix accumulation) may 
also reflect the time history of the system and the influence of other regulatory 
mechanisms. Aggrecan core protein undergoes co- and post-translational modifications, 
and may be subject to processing or secretory errors (Luo et al., 2000; Vertel, 1995). It 
may be that not every cell that produces core protein can appropriately modify the core 
and secrete it into the extracellular space. Furthermore, integration and retention of 
aggrecan core protein within the extracellular matrix relies on association with the 
hyaluronic acid and collagen network and other molecules (Knudson, 1993; Vertel, 1995), 
and even aggrecan that has been integrated into the established matrix may ultimately be 
degraded by aggrecanases produced locally (Caterson et al., 2000). Deficiencies in any 
of these steps could decouple even temporally constant aggrecan mRNA expression from 
aggrecan core protein accumulation in the pericellular space. However, our transcriptome-
wide data suggest that there is not a transcript level correlation between functional 
capacity and any of the genes involved in these processing steps. 
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Collectively, our findings in MSCs show that instantaneous aggrecan expression is only 
tenuously connected to matrix deposition. Moreover, differentiation of these cells fails to 
recapitulate the potential of native chondrocytes and does not prevent the expression of 
markers of alternate lineages even at the single-cell level. Our finding that chondrocyte 
expression of aggrecan does not decrease with de-differentiation also supports this weak 
connection, and raises questions as to the role of marker gene expression in defining 
phenotype. While aggrecan is one of the most conventional markers for the cartilage 
phenotype, its absolute expression did not correlate with cartilage-like matrix production 
and did not change as cells ‘de-differentiated'. If aggrecan expression does not change, 
other elements of the cell must be responsible for shifting cell fate and altering the 
transcriptional ‘focus' of the cell. Here our finding of major shifts in GAPDH with minor 
changes in aggrecan during de-differentiation suggest that de-differentiation may be better 
characterized as a shift in cell focus rather than a loss in specific programmatic expression 
of marker genes. While it is not yet clear what cell-wide changes drive this process, future 
work utilizing transcriptomics may identify a more comprehensive set of markers that are 
predictive of differentiated cell function. Until phenotype and its basis in gene expression 
are more precisely defined, our results suggest that it may be ineffective to design 
therapies that seek to bolster phenotype by increasing expression of individual genes or 
regulating transcriptional control of individual promoter regions, even for those genes 
whose products are directly related to functional matrix assembly. Simply increasing the 
raw RNA signal available to the cell may be insufficient, and it may also be necessary to 
alter the transcriptional context in which this occurs. These findings challenge the 
traditional notion that marker gene expression defines or is even strongly associated with 
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the chondrocyte phenotype and identify new directions in progenitor cell biology to 




Chapter 3: Variability in splicing from one intron to the next 
Introduction 
The mRNA transcribed by most eukaryotic genes are spliced, a process in which the 
intronic RNA sequence is removed and the exonic RNA are joined together to form the 
ultimate mRNA sequence. A major question in the field is how tightly associated the 
process of transcription and splicing are, with some work suggesting that splicing tracks 
closely behind the RNA polymerase as it transcribes, while other work suggests that many 
RNAs are fully transcribed before splicing occurs. The degree of coupling is thought to be 
important for the process of alternative splicing, such that different parts of the RNA are 
spliced together, and is a major source of transcriptomic diversity. Specifically, it is often 
postulated that it is necessary to completely transcribe the RNA before making a splicing 
“choice”, implying that genes need to be spliced post-transcriptionally in order to make 
that choice. The fact that alternative splicing has been shown to exist for >95% of genes 
in mammalian cells (Pan et al., 2008) suggests that many genes may need to be spliced 
post-transcriptionally. The relative spatial locations of nascent pre-mRNA, fully transcribed 
pre-mRNA, and mature mRNA species have the potential to directly reveal where—and 
consequently in what order—the processes of transcription and splicing are occurring. 
However, to date, there have been only limited studies using molecular imaging to 
systematically measure the locations of these RNA intermediates. This gap has largely 
been due to the limits of optical resolution and the design of probes to specifically 
interrogate these intermediates. 
In lieu of direct visualization, many have turned to biochemical fraction to infer the 
location of various intermediates (Bhatt et al., 2012; Drexler et al., 2019; Mayer et al., 
2015; Pandya-Jones et al., 2013; Pandya-Jones and Black, 2009; Tilgner et al., 2012; 
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Wuarin and Schibler, 1994). Fractionation methods separate the cell into different 
compartments, such as the putatively chromatin associated RNA, nucleoplasmic RNA, 
and cytoplasmic RNA, by centrifuging the cellular components in different lysis buffers and 
sedimentation gradients (Mayer and Churchman, 2017). The inherent assumption made 
by such fractionation based methods is that the RNA species in the chromatin fraction 
represent nascent pre-mRNA that is still tethered to the gene body by the RNA polymerase 
II itself, and that once the pre-mRNA is fully transcribed, the pre-mRNA immediately 
moves into the nucleoplasm. Under these assumptions, any splicing observed in the 
chromatin fraction would be assumed to be co-transcriptional. However, this assumption 
may not hold: it is possible that the pre-mRNA remains in a chromatin associated 
compartment for some time after transcription completes, and thus splicing observed in 
chromatin compartment may still be post-transcriptional. Some groups have tried to test 
this assumption explicitly by isolating nascent RNA via metabolic labeling or the use of 
RNA Polymerase II antibodies, but these methods are still prone to contamination by 
nearby RNA. Ultimately, such alternatives are difficult to resolve without an independent 
and explicit verification of which RNA intermediates reside in particular compartments. 
Meanwhile, advances in RNA imaging have enabled researchers to image RNA 
intermediates with single molecule resolution, both in fixed and living cells (Coulon et al., 
2014; Levesque and Raj, 2013; Martin et al., 2013; Vargas et al., 2011; Waks et al., 2011; 
Zhang et al., 1994). Imaging using probes targeted both exonic and intronic regions of 
RNA has revealed bright nuclear foci that represent nascently transcribing RNA (Levesque 
and Raj, 2013; Vargas et al., 2011). The general lack of intronic signal away from these 
transcription sites has been taken as evidence for co-transcriptional splicing, with notable 
cases of post-transcriptional splicing at speckles being observed in special cases (Vargas 
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et al., 2011). However, these studies have a number of limitations. Firstly, owing to 
limitations in optical resolution, it has been difficult to visualize RNA intermediates in the 
peri-transcriptional region, thus making it difficult to see whether RNA are tethered to the 
site of transcription for splicing or dwell at the site of transcription after transcription is 
complete. Since splicing would appear to occur in the chromatin fraction in both of these 
scenarios, it is possible that much splicing is actually occurring in this peri-transcriptional 
region. Indeed, recent live imaging methods showed that splicing of a reporter gene 
happens 85% post-transcriptionally, suggesting the latter, but the use of reporter genes 
leaves open the question of how general such results are, given that RNA from 
endogenous genes may be processed differently. 
Here, we designed probes to comprehensively interrogate the spatial localization of 
several RNA intermediates using a combination of RNA FISH and expansion microscopy 
(Chen et al., 2016, 2015) to reveal the ordering of transcriptional and splicing processes 
with single molecule resolution.  We find that the portion of splicing that occurs post-
transcriptionally varies from intron to intron within a single gene, but that all endogenous 
genes display some degree of post-transcriptional splicing. We also employ expansion 
microscopy to demonstrate that newly synthesized RNA dwell and undergo continuous 
splicing near the site of transcription after transcription is complete. These RNA are 
untethered to the site of transcription and eventually diffuse into either the nucleoplasm or 




At least one intron of each observed endogenous gene is spliced post-transcriptionally 
To directly visualize the locations of spliced and unspliced RNA relative to the 
transcriptional locus, we used RNA FISH to simultaneously label the exons and several 
individual introns of the genes of interest. Briefly, we used a series of tiled oligos 
conjugated to fluorescent molecules that are bound to an RNA with a complementary 
sequence to the oligos chosen. This allowed us to simultaneously observe introns and 
exons of the same gene in single cells. This revealed information about the splicing status 
of that gene by labeling the locations of splicing intermediates (represented by colocalized 
intron and exon spots) relative to the site of transcription (represented by bright colocalized 
intron and exon spots) and fully spliced products (represented by exon spots alone). 
Visualization of splicing intermediates allowed us to distinguish between two 
possibilities: 1) RNA being spliced at the site of transcription and 2) RNA being spliced 
away from the site of transcription (Figure 6A). Observing spliced RNA at the site of 
transcription could represent RNA that is spliced either co-transcriptionally (tracking along 
with or shortly behind the polymerase) or proximally post-transcriptionally (near the site of 
transcription but after the process of transcription has been completed) (Figure 6A). If we 
observe unspliced RNA that is far away enough from the site of transcription that it could 
no longer be attached to the location of the gene itself, it would suggest that RNA is being 
spliced post-transcriptionally (distal post-transcriptional splicing, Figure 6A).  
To determine what fraction of splicing occurred post-transcriptionally, we first needed to 
classify each spot as either a transcription site or a dispersed pre-mRNA. We 
computationally identified spots for both introns and exons of a particular gene, then each 
intron spot that was within .65uM of an exon spot was designated a colocalized exon and  
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Figure 6: At least one intron 
from every tested 
endogenous gene is post-
transcriptionally spliced. 
A) Schematic depicting three 
categories of splicing. B) 
Schematic depicting RNA FISH 
method and translation of RNA 
FISH images into dispersal 
graphs. C) Graphs indicating 
dispersal distance or the 
distance of each detected pre-
mRNA to its nearest 
transcription site. D) Example 
images of dispersed (intron 4) 
and not dispersed (introns 1 and 
3) transcription sites, via RNA 
FISH.  
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intron spot (Figure 6B), which we believe represents at least one pre-mRNA (potentially 
several pre-mRNAs when found at the site of transcription). Intron spots that did not 
colocalize with an exon spot were presumed to be degradation products or non-specific 
background and were discarded, though these were generally <25% of intron spots (Table 
2). We used an intensity threshold to categorize each colocalized exon and intron spot as 
either a transcription site or a dispersed pre-mRNA (Figure 6B, see Supplementary Figure 
5A,B for more information about the classification of transcription sites).  We then 
displayed the distance of each dispersed pre-mRNA from its nearest transcription site for 
all cells on a single graph to display all dispersal per intron (Figure 6C). We found that for 
the four genes tested, at least one intron displayed some splicing intermediates away from 
the site of transcription (3-5 introns tested per gene, Figure 6C). This suggests that some 
introns (for which we see splicing intermediates far from the site of transcription) are being 
spliced post-transcriptionally. 
We made the assumption that intron containing pre-mRNA away from the site of 
transcription are post-transcriptionally spliced, and not degraded. This assumption holds 
because the number of remaining unspliced introns decreases with distance from the 
transcription site, suggesting that introns are excised progressively as transcripts get 
further away from the transcription site (Supplementary Figure 5E).  
Given that individual introns within the same gene displayed differing levels of dispersal, 
we asked whether the degree of dispersal could depend on the order in which transcription 
occurs or whether the introns are being spliced independently of transcriptional order. To 
test this, we We didn’t observe an increase in dispersal on a 5’ to 3’ basis (Figure 6C). 
This lack of increased dispersal on a per gene basis suggests that the introns are being 
spliced not in a 5’ to 3’ order (Figure 6C).  
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The differential dispersal of each intron within a gene suggests that each intron has a 
particular splicing rate which governs the time it takes until that intron is spliced, apparently 
independently of neighboring introns.  
 
Transcripts are untethered to the site of transcription and dwell at the site of transcription 
after transcription is completed 
 
While conventional RNA FISH allowed us to determine what portion of splicing is 
happening distally post-transcriptionally (Table 2, Supplementary Figure 5C), the 
resolution limits of conventional light microscopy made it difficult to distinguish whether 
splicing at the site of transcription was happening co-transcriptionally or proximally post-
transcriptionally. It was impossible to distinguish whether transcripts are being spliced 
during the process of transcription or after the process of transcription has been completed 
because conventional light microscopy cannot distinguish which RNA at the site of 
transcription are being actively transcribed or have completed transcription. It is difficult to 
distinguish those two possibilities because, with conventional light microscopy, all of the 
RNA at the site of transcription are only visible together as one large transcription site 
spot. 
In order to visualize individual RNAs and proteins at site of transcription, we used a 
combination of expansion microscopy and RNA FISH to expand the transcription site and 
visually identify single spots at the site of transcription, instead of a bright blob (Figure 7A, 
B). We knew that spots at these sites represent completed or almost completed transcripts 
because we observed multiple spots in a cloud from our 3’ probe set, which targets 
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of the RNA is largely transcribed (Figure 7C,D). We therefore hypothesized that these 
are pre-mRNA or mRNA moving away from the site of transcription, but their localization 
to adiscrete region suggest that there is a proximal region to the site of transcription 
through which the RNA are moving slowly, potentially where splicing is still occurring. 
In addition to these 3’ clouds, we observed that the 5’ and 3’ ends of the pre-mRNA at 
the site of transcription are farther apart than their cytoplasmic counterparts (Figure 7D), 
suggesting that either the RNA is stretched more than cytoplasmic RNA, or they are longer 
because there are more introns incorporated into the RNA. The 3’ spot clouds suggest 
two things: 1) that transcripts move slowly through a region proximal to the transcription 
site and are untethered to the gene during this movement, or we would expect to see tight 
3’ spot colocalization (Figure 7A,C) and 2) that transcripts dwell after completion at the 
site of transcription, or we would expect to see both tighter 5’ and 3’ spots (Figure 7A,C). 
If transcripts did not dwell at the site of transcription, we would expect to see only actively 
transcribed nascent RNA at the site of transcription (forming a tight cloud around 
polymerase II puncta), but the presence of many 3’ spots suggest that there are many 
RNA that are not actively being transcribed.  
To confirm that the RNA at the site of transcription are not actively being transcribed, we 
co-stained with actively elongating polymerase II (phosphoS2)(Figure 7G,H). The lack of 
Figure 7: Transcripts dwell at the site of transcription after transcription is completed. 
A) Schematic depicting potential scenarios for RNA immediately after the process of transcription 
completes. B) Gene and probe position diagram for CPS1 pre-mRNA and mRNA. C) example images 
of RNA FISH before and after expansion microscopy for individual mRNA and transcription sites. D) 
Distance from 5’ to 3’ of expanded and unexpanded mRNA and transcription sites, as detected by 
CPS1 RNA FISH. E) Example images of 5’ and 3’ CPS1 RNA FISH after expansion. F) Quantification 
of E and other images, CPS1 RNA FISH after expansion microscopy. G) Example images of co-IF 
(polymerase II) and RNA FISH for CPS1 after expansion. H) Quantification of images like that in G, 
and others, representing distance from each RNA spot to the nearest polymerase II IF spot.  
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active transcription is confirmed by the observation that there are many 3’ spots that do 
NOT localize with actively elongating polymerase II (Figure 7H). We observe that the 
mean and median distances of 3’ spots to polymerase II is greater than the majority of 
expanded mRNA, suggesting that most spots are too far away from polymerase II to be 
actively being transcribed.  
Taken together, this data suggests that many transcripts proximal to the site of 
transcription are not actively being transcribed but are instead moving slowly through a 
small zone around the site of transcription, where they are untethered to the site of 
transcription but still in the process of being spliced. 
 
Sequencing corroborates RNA FISH dispersal results 
 
To corroborate our RNA FISH results, we turned to sequencing of nascent RNA to 
determine the splicing status of RNA that has recently been transcribed and compared 
that to our dispersal metrics. Nascent RNA was isolated by a combination of metabolic 
labeling of newly synthesized RNA and isolation of RNA that cosediments with the 
chromatin fractions of cells. This isolated RNA was then subject to standard high 
throughput sequencing methods and we calculated a “splicing index” per intron that is 
defined as the number of spliced reads for a given junction divided by the number of 
unspliced reads for the same junction (Figure 8A). This splicing index represents how “co-
transcriptionally spliced” a particular intron is, introns with a high splicing index are very 
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Sequencing of this metabolically labelled and chromatin associated RNA also suggested 
that introns have variable splicing even within endogenous genes (Supplementary Figure 
6A). Applying our splicing index to the introns that we have dispersal data for shows a 
variable splicing index from intron to intron (Supplementary Figure 6A). Directly comparing 
splicing index and mean dispersal shows an inverse relationship, as expected, introns with 
a high splicing index (very “co-transcriptionally” spliced) have low dispersal, and introns  
  Figure 8: Sequencing 
corroborates RNA FISH 
dispersal results. A) Schematic 
of sequencing experiment 
design. B) Comparison of mean 
dispersal (as assessed by RNA 
FISH, see Figure 6) and mean 
splicing index (as assessed by 
sequencing). 
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with a low splicing index (very “post-transcriptionally” spliced) have high dispersal 
(Figure 8B). However, there are a number of introns for which both the splicing index and 
mean dispersal were low, suggesting that these low-splicing-index and low-dispersal 
introns are subject to technical noise or there may be a great deal of “proximal post-
transcriptional” splicing, which would result in low dispersal but also a low splicing index.  
We also analyzed transcription site size for each intron for which we have FISH data 
(Supplementary Figure 6B), which we anticipated would be another metric by which we 
can measure proximal post-transcriptional splicing because large transcription sites may 
represent high numbers of “dwelling” RNA that are done with transcription but being 
actively spliced proximal to the site of active transcription. Similar to mean dispersal, RNA 
FISH-based analysis of transcription site size also displays an inverse relationship with 
splicing index; however, there remain several ambiguous introns in the lower left quadrant 
of the graph that have both low splicing index (very “post-transcriptionally” spliced) and 
low transcription site size (Supplementary Figure 6B).  
The anticorrelation of splicing index with both mean dispersal and transcription site size 
suggests that sequencing of nascent RNA corroborates mean dispersal and transcription 
site size as methods to assess the amount of post-transcriptional splicing occurring. 
 
A fraction of unspliced pre-mRNA localize to a speckle-proximal compartment after 
exiting a slow moving zone proximal to the transcription site 
 
We wondered where transcripts went after they were released from the slow-moving 
transcription-site-proximal zone that was revealed by expansion microscopy. We 
hypothesized that the transcripts could do one of three things: 1) freely diffuse away from  
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the transcription site, 2) be tethered to the site of transcription, 3) fill a compartment, 
potentially around or adjacent to the site of transcription or other nuclear bodies (Figure 
9A). 
However, there were relatively few unspliced RNA that made it out of that transcription-
proximal zone, making it difficult to characterize the behavior of these pre-mRNA. Thus, 
we inhibited splicing to generate more pre-mRNAs making it easier to quantify their 
behavior.  
Upon splicing inhibition, we observed three distinct phenotypes for pre-mRNA species, 
one in which there are increased dispersed pre-mRNA throughout the nucleus (nuclear 
dispersal genes), one in which the pre-mRNA move into a small compartment, likely to be 
around the site of transcription or another nuclear body (compartmentalization genes), 
and one in which the transcription sites look identical to transcription sites before splicing 
inhibition (non-responsive genes) (Figure 9B,C). The compartmentalization phenotype 
only appeared for three tested genes (out of 16): EEF2, GAPDH, and RPL13A (Figure 
9C), whereas we observe a nuclear dispersal phenotype for 7 genes and no response for 
6 genes (Figure 9H). 
One of our hypotheses was that these pre-mRNA might be tethered to some location 
within the nucleus, whether that be the DNA that they are transcribed from or a point within 
the compartments that we observe. However, it is likely that these pre-mRNA are filling up 
a compartment and are not tethered within this compartment because we observe full 
colocalization of 5’ and 3’ exons within the compartment (Figure 9D), whereas we might 
otherwise expect a tighter colocalization of one section (5’, middle, or 3’) of the RNA if the 
RNA were tethered to one specific point within the compartment (Figure 9A, 
Supplementary Figure 7A).  
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Figure 9: Some transcripts localize to a 
speckle proximal compartment after splicing 
inhibition. 
A) Schematic of possibilities for RNA movement 
post- transcription. B) Example images of introns 
of specified genes before and after pladienolide B 
treatment. C) Description of 3 response types to 
pladienolide B. D) EEF2 RNA FISH exon and 
intron images. Scale bar = 5um. E) EEF2 RNA 
FISH intron images. Scale bar = 5um. F) 
Specified RNA FISH intron images. Scale bar = 
5um. G) Costaining of RNA FISH for specified 
intron and SC35 IF in the same cell. Scale bar = 
5um. H) Quantification of speckle decile from 




We also observe that multiple introns from the same gene colocalize to the same 
compartments (Figure 9E), suggesting that all unspliced pre-mRNA from a gene localize 
to the same compartments. Additionally, we also observe multiple genes localize to a 
similar set of compartments (Figure 9F). Two of these genes are located to opposite ends 
of the same chromosome (EEF2 and RPL13A, chromosome 19) and the third gene is 
located on a separate chromosome (GAPDH, chromosome 12) (see Supplementary 
Figure 7B for karyotype). However, when observing the three genes before splicing 
inhibition, they do not appear to colocalize with one another, suggesting perhaps that the 
compartments they colocalize to after splicing inhibition may be somehow targeted by 
these genes after splicing inhibition.  
We wondered if these compartmentalized pre-mRNA were located near any other 
nuclear structures. One candidate was nuclear speckles, which are compartments in the 
nucleus that contain concentrated splicing and transcription factors (Spector and Lamond, 
2011). To determine whether these compartments colocalize with nuclear speckles, we 
performed RNA FISH simultaneously with immunofluorescence for SC35, a component of 
speckles, and see that these compartmentalized pre-mRNA do indeed colocalize with 
nuclear speckles both before after splicing inhibition (Figure 9G, Supplementary Figure 
7D). This association between speckles and compartmentalized pre-mRNA is confirmed 
by previously published high throughput sequencing data that quantified the distance of 
transcripts from speckles and other nuclear compartments (Chen et al., 2018). From that 
data, we find that compartmentalized genes are all within the most speckle associated 
decile of the data, and all other tested genes (both nuclear dispersal and non-responsive) 
exhibit a range of distances to speckles (Figure 9H).   
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This data suggests that pre-mRNA from specific genes are sequestered into speckle-
proximal compartments before splicing occurs.  
 
Intron splicing rate is not an inherent trait of individual introns and can vary with 
transcription level 
 
We wondered whether splicing rate (as represented here by dispersal), was an inherent 
property of each intron tested or whether the splicing could vary with context, such as 
transcription level. To test whether splicing rate was an inherent property of introns, we 
treated A549 cells with dexamethasone to induce transcription of the gene FKBP5, and 
then performed RNA FISH along varying time points in dexamethasone and assessed 
dispersion (Figure 10A, B). Over time, we see an increase in both exon and intron spot 
counts (Figure 10B), and a corresponding increase in intron dispersal (Figure 10C) but 
only for certain introns. The fact that dispersal increases with transcription level for these 
introns suggests that dispersal is therefore not an inherent property of each intron but 
depends on local context (Figure 10C). However, some introns do not exhibit an increase 
in dispersal even with long exposure to dexamethasone (8 hours) (Figure 10C), 
suggesting that some introns may have a splicing rate that is fast enough to still exhibit 
transcription site localized splicing even in case of increased transcription. This data 
suggests that dispersal, or the percentage of splicing that happens distally post-
transcriptionally, can vary with gene context, such as transcription level, and is therefore 
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Figure 10: Intron dispersal varies with transcription level and is therefore not an inherent 
property of each intron. A) Gene and probe diagram for FKBP5 and schematic of dexamethasone 
treatment schedule. B) Quantification of FKBP5 RNA FISH exon and intron spots over time of 
treatment in dexamethasone. C) Dispersal graphs (as quantified from RNA FISH) of FKBP5 introns 1, 















% of intensity that is not 
local to txn site 
CPS1 1/37 10 75.5814 0 0 
CPS1 13/37 12 88.2716 0.067485645 1.337543 
CPS1 21/37 24 74.71264 2.0966995 27.7981585 
CPS1 34/37 16 88.88889 0.03229656 1.952689 
EEF2 1/14 21 91.66667 0.93700431 15.69285 
EEF2 2/14 21 91.73554 0.41633783 6.482196 
EEF2 11/14 13 94.08867 1.67628235 24.386486 
TM4SF1 1/4 17 98.59155 0 0 
TM4SF1 3/4 24 94.78261 0.34731502 2.422979 
TM4SF1 4/4 24 87.84648 3.00480873 47.094267 
FKBP5** 1/10 32 77.52809 1.2286272 22.451107 
FKBP5** 3/10 32 94.64286 0.4514456 3.692255 
FKBP5** 5/10 32 73.4375 2.852407 6.836791 
FKBP5** 8/10 32 81.41593 1.4870159 33.077603 
FKBP5** 9/10 14 93.89671 0.5677152 3.679758 
FKBP5** 10/10 11 71.60494 0 0 
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Discussion 
Our results suggest the following model of splicing: first, the mRNA is transcribed. 
Splicing occurs continuously and independently between different introns while 
transcription is occurring and also while the pre mRNA moves slowly through a region 
proximal to the transcription site, after which it moves either to the speckle compartment 
or freely in the nucleoplasm. This is in contrast to prevailing ideas of splicing, which 
suggest that splicing happens immediately (within 15-20 seconds or 45-100 nucleotides 
of transcription) after transcription of each intron is completed (Alpert et al., 2016; Carrillo 
Oesterreich et al., 2016; Eser et al., 2016; Huranová et al., 2010; Martin et al., 2013; 
Wallace and Beggs, 2017). This contrast may be due to a variety of different reasons, 
including but not limited to species specific differences and the use of different assays to 
measure the timing of splicing (Alpert et al., 2016).  
We see that introns of most endogenously expressed genes are spliced in a variety of 
spatial distributions, with all the genes we probed demonstrating at least one intron with 
some splicing occurring distally from the transcription site. This suggests that each intron 
has a distinct splicing rate, with at least one intron for each gene spliced partly distally 
post-transcriptionally. Our results also suggest that introns are spliced independently of 
one another, whether they are proximal or distal to each other. This is in contrast to other 
work which suggests splicing of particular introns is controlled or gated by the splicing of 
other introns or exons within the same gene (Kim et al., 2017).  
One of the original models for splicing is the “first come, first serve” model in which each 
intron is immediately spliced upon the completion of transcription, in a 5’ to 3’ order (Aebi 
and Weissman, 1987). Our results suggest that this is not the case, based on seeing low 
splicing rates (or high dispersion) for even the 5’ most introns of some genes. This lack of 
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first come, first serve splicing is confirmed by others in several different situations (de la 
Mata et al., 2010; Kessler et al., 1993; Yang et al., 2012). 
Our expansion microscopy results also suggest the existence of a region proximal to the 
gene through which the pre-mRNA moves slowly before being allowed to freely move 
through the nucleus for export. The slow movement through this region may be caused 
by already existing chromatin structures or may be due to a concentration of protein factors 
that is created by the process of transcription itself, and the transcription associated 
processing steps such as capping and polyadenylation. Work by Pandaya-Jones et al. 
and Bhatt et al. suggests that fully transcribed but unspliced RNA remain in the chromatin 
compartment (the RNA that cosediments with chromatin after centrifugation) and are fully 
spliced before release into the nucleoplasm (Pandya-Jones et al. 2013; Bhatt et al. 2012), 
which would be consistent with RNA moving slowly through a transcription site proximal 
compartment while the process of splicing is completed. 
Our results also suggest that pre-mRNA are not tethered to the site of transcription while 
they move through this transcription site proximal compartment. This is in contrast to what 
is suggested by Dye et al., where they suggest that exons are tethered to polymerase II 
as splicing is occuring (Dye et al. 2006). The lack of colocalization of introns with 
polymerase II also suggests that splicing is not happening with polymerase II immediately 
downstream of those introns. This contrasts the data of Alexander et al., which suggest 
that almost all splicing occurs while polymerase II is still paused proximal to the intron that 
was recently transcribed (Alexander et al. 2010). This may be due to species specific 
differences, however, there have been many links between polymerase II pausing and 
splicing (for a review, see (Carrillo Oesterreich et al. 2011)).  
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In addition to a slow moving transcription proximal compartment and lack of an RNA-
gene tether, our expansion microscopy suggests that the distance between the 5’ end and 
the 3’ end of RNA at the site of transcription is greater than the distance between the 5’ 
end and 3’ end of mRNA. This increased 5’-3’ distance suggests that the transcripts at the 
site of transcription  are either unpackaged, perhaps due to decreased RBP occupancy, 
or are simply longer because there are likely more introns incorporated close to the site of 
transcription than away from it. If this 5’ to 3’ distance increase is due to increased 
incorporation of introns, this would challenge the idea that splicing is happening 
immediately post-transcription. 
We also wondered what happens to unspliced pre-mRNA that escape this slow-moving 
transcription proximal compartment. Our splicing inhibition results suggest that some 
genes localize to a speckle-proximal compartment after escape, and some move freely 
through the nucleoplasm, with some dependence on pre-splicing inhibition speckle 
association. The consistency of our observation with another speckle associated metric 
across cell types and assays suggests that the speckle association of these genes might 
be constitutive (Chen et al. 2018). We also observe that pre-mRNA of 
compartmentalization genes seem exclusively localized to this speckle-proximal 
compartment, perhaps as a way to sequester the unspliced RNA. It is possible that escape 
of these unspliced compartmentalized pre-mRNA away from the site of transcription and 
into the cytoplasm for translation may be particularly deleterious for a cell because those 
genes displaying a compartmentalization phenotype are all important genes (Curtis et al., 
2010; Kapp and Lorsch, 2004; Nicholls et al., 2012). It is also possible that these RNA, 
because of their abundance, sequence factors, or associated RNA binding proteins, are 
more likely to integrate into compartments, such as nuclear speckles (Chen et al., 2018). 
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We also see that increased transcription level correlates with intron dispersal, which 
suggests that the percentage of splicing that happens distally post-transcriptionally is 
regulated by transcription level for at least some introns. This may also explain why we 
observe the post-transcriptional splicing of all genes measured as all of them were highly 
expressed. Work by Ding and Elowitz suggests that, for high expressing genes, splicing 
can act as an “economy of scale” filter, in which the expression of already highly expressed 
genes is amplified by increased splicing efficiency, potentially due to association with 
nuclear speckles (Ding and Elowitz 2019).  
Taken together, our data challenge the longstanding idea that splicing is happening 










In this thesis, I address two separate questions:  
1) How do we pick “good” mesenchymal stem cells? 
2) Is splicing happening co-transcriptionally? 
I use a variety of methods to address these questions, but most of my methods used 
focused on characterizing the cell-to-cell variability in transcription and splicing, 
respectively.  
My results suggest that, despite the marked heterogeneity in marker expression in 
naive mesenchymal stem cells, traditional markers of chondrocyte function will not identify 
high performing mesenchymal stem cells initially after isolation, or even after the process 
of differentiation. This may be due to many factors which require further investigation, such 
as modulation of genes in the secretory pathway or defects in post-translational 
modifications of extracellular matrix proteins. Regarding variability in transcription, it is 
likely that much of this variation is due to the bursting nature of transcription (Raj et al., 
2010, 2006; Raj and van Oudenaarden, 2008). It has been established that transcription 
occurs in discrete bursts, as opposed to continuously, for almost all genes (Suter et al., 
2011). These bursts, when infrequent, could result in the massive variability that we see 
in expression levels of marker genes in mesenchymal stem cells. With infrequent bursts, 
cells with high expression at one moment in time may not experience another burst until 
all of their mRNA are degraded, leading to the observed lack of “cellular memory” that we 
see with recently divided mesenchymal stem cells. This lack of cellular memory may 
explain one reason why traditional markers do not represent high performing 
mesenchymal stem cells. 
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In addition to the variability in expression in mesenchymal stem cells, our study of 
variability in chondrocyte marker expression suggests that absolute expression of the 
markers measured also do not reflect high performing chondrocytes, especially after time 
in monolayer culture. This suggests that cellular context is particularly important in this 
case.   
In the future, I would continue this work by using the transcriptome data generated with 
new sequencing analysis tools that might allow us to make use of the continuous variable 
data like GAG deposition of each clone. I would use this transcriptome data to determine 
which cell surface markers could be of use to sort mesenchymal stem cells out for their 
ultimate cartilage tissue engineering performance. I could then test this by actually sorting 
and differentiating mesenchymal stem cells. In addition, I believe it is necessary to study 
several other aspects of cartilage extracellular matrix deposition to determine where the 
breakdown occurs between expression of traditional markers and their ultimate deposition. 
Several likely candidates include post-translational modifications of these proteins, as 
aggrecan especially is heavily glycosylated post translationally, and defects in the 
secretory pathway, which may prevent proteins produced from being deposited into the 
extracellular space.  
My splicing results challenge the assumption that splicing is happening immediately 
post-transcriptionally, and suggest that transcripts dwell at the site of transcription after 
transcription is complete. The timing of splicing is well studied, and the global percentages 
of co-transcriptional splicing found by others ((Brugiolo et al., 2013), 16-55% globally post-
transcriptional) are in agreement with the percent of mRNA that I see as distally post-
transcriptionally spliced (0-47%). However, my findings with expansion microscopy also 
suggest that there is a great deal of post-transcriptional splicing proximal to the site of 
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transcription. This is in agreement with more stringent fractionation and sequencing 
methods (Drexler et al., 2019), but in contrast to many traditional fractionation methods 
(Carrillo Oesterreich et al., 2016; Tilgner et al., 2012).  
In the future, I would continue this work by continuing to use a combination of expansion 
microscopy and RNA FISH to confirm the dwell time and lack of tether observations for 
other genes of interest. In addition, it seems likely that at least some of the regulation of 
timing of splicing of these introns is due to sequence specificity, but I was unable to 
determine what the specific source of this sequence specificity was (data not shown), It 
would be of interest to take sequences, compare to mean dispersal or transcription site 
size, and analyze which features can explain the greatest diversity in splicing dynamics. 
Similarly to published work (Drexler et al., 2019), I found no sequence determinants that 
could explain my observations of post-transcriptionality, but it is likely that there is some 
currently unexplored aspect of sequence specificity that could explain these differences. 
This could potentially also be illuminated by experiments such as pulldown of the RNAs 
of interest (a comparison of highly dispersed and highly undispersed) followed by a 
proteomics based quantification of their respective RNA binding proteins, which may 
illuminate which factors are responsible for the differences in splicing rates, if any. It is 
possible that this difference in splicing rates could be also be based on the presence of 
alternative splice sites within the introns of interest, potentially “confusing” the 
spliceosome, and forcing the spliceosome to take longer to identify the canonical splice 
sites. This would also be illuminated by further exploration into the sequence specific 
differences between the multiple introns that exhibit different dispersal patterns.  
Taken together, my data suggest that cell-to-cell heterogeneity can be due to many 




























































































Supplementary Figure 1: Matrix production, GAPDH copy number, and viability of MSCs in 3D culture.
a) Alcian blue staining for sulfated proteoglycans for MSCs in 3D culture, for all donors and time points,
with and without
b) Mean GAPDH RNA counts and c) cell viability over 21 days in 3D culture. Narrow bars represent the
mean within an individual donor; overlaid bars represent the mean across donors. Error bars indicate
standard error (n = 24-128 cells per donor and condition). RNA count means compared by t-tests with
Satterthwaite approximation and simulated adjustment for multiple comparisons. See SupplementaryTable 4
for all statistical comparisons. d) Simultaneous RNA FISH and fixable dead staining established a threshold
of GAPDH>10 to differentiate live cells from dead cells for further analysis.
n = 85 cells for
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Supplementary Figure 2: Matrix staining intensity versus mRNA copy number and ROC curves for individual 
donors, markers, and marker ratios. a) Distribution of aggrecan, GAPDH, osteopontin, aggrecan/GAPDH, 
and aggrecan/osteopontin gene expression within high- and low-performing MSC populations; separated by 
donor. Dashed lines represent the mean for each condition. For aggrecan/osteopontin, only cells that had at 
least one osteopontin (>95% of cells per donor) mRNA were included in the graph and mean statistics 
calculation. b) Receiver operating characteristic curves using individual gene expression and gene 
expression ratios to distinguish between high- and low-performing MSCs, separated by donor. Cells/donor: 
D: 132, E: 153, F: 122, X: 57, Y: 42, Z: 47.  



















































































































































Supplementary Figure 3: Heritability of marker copy number through cell division.
a-b) Divergence in gene expression between sister cells as a function of time since their last division.
c) Divergence in GAPDH vs aggrecan and d) osteopontin vs aggrecan between sister cells as a function
of time since their last division.
Box hinges denote the first and third quartiles. Whiskers extend from the hinges to the most extreme
data points within (1.5 * interquartile range) of the hinges.  Means compared by t-tests with Satterthwaite
approximation and simulated adjustment for multiple comparisons, *** indicates p<0.001,* p<0.05. See






























Supplementary Figure 4: Chondrocyte morphology with passage number.
Chondrocyte spread area with increasing passage number during de-differentiation
(n = 25-27 cells per donor per condition). Narrow bars represent the mean within an
individual donor; overlaid bars represent the mean across donors. Error bars indicate
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Supplementary Figure 5: 
Transcription site 
choice and defining 
post-transcriptionality. 
A) Histograms of intron 
intensities for TM4SF1 
intron 4, before after, and 
during defining a global 
thresholding cutoff. 
Example of how the global 
cutoff is chosen for 
transcription sites. B) 
Example classification of 
pre-mRNA as either 
transcription sites or 
dispersed pre-mRNA. C) 
.Distances between 5’ and 
3’ ends of RNA as 
detected by RNA FISH for 
either the 3’ or 5’ end of 
the RNA of interest. D) 
Example classification of 
RNA as “distal” or 
“proximal” to the 
transcription site E) 
Histogram showing type of 
pre-mRNA as defined by 
RNA FISH, as a function 







































Supplementary Figure 6: Splicing index varies on a per intron basis. A) 
Splicing index of each intron for which we obtained RNA FISH 
measurements. Error bars represent mean +/- sd. n = 2 B) Comparison of 
transcription site size (as assessed by RNA FISH) and splicing index, as 
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Supplementary Figure 7: Compartmentalization 
genes before splicing inhibition. 
A) Schematic of compartmentalization phenotype 
with and without tether. B) Our lab’s HeLa 
karyotype, reproduced from Levesque and Raj, 
2013. C) RNA FISH of RPL13A, EEF2, and 
GAPDH introns before pladienolide B treatment. 
Scale bar = 5 µm. D) Combined RNA FISH for the 
stated introns and IF for SC35, before pladienolide 











Appendix 1: Materials and Methods 
Chapter 2 Methods 
Cell isolation and expansion 
MSCs were isolated from the tibial and femoral bone marrow of juvenile bovine cows 
(3–6 months, Research 87, Boylston, MA) and expanded in a basal media consisting of 
high-glucose DMEM with 10% FBS and 1 × antibiotic–antimycotic. After the initial plating 
reached ∼80% confluence, cells were passaged at a ratio of 1:3 before use in 
experiments. For single-cell-derived colonies, bovine MSCs were isolated as described 
above and seeded sparsely onto glass coverslips. Individual colonies were allowed to 
expand for 3 days in basal media, followed by 4 days in chondrogenic induction media 
before fixation. All cells in each colony were manually located and imaged as described 
below. Chondrocytes were isolated from articular cartilage from the trochlear groove of 
juvenile bovine knees. Cartilage was digested in basal media supplemented with type II 
collagenase (0.5 mg ml−1, Sigma-Aldrich) for up to 18 h. Isolated cells were filtered, 
washed and plated in basal media. To improve cell yield for chondrocyte re-differentiation 
studies, cartilage was also digested in basal media with pronase (2.5 mg ml−1, 
Calbiochem) for 1 h before collagenase digestion. For all studies, chondrocytes were 
expanded in basal media and passaged 1:10 when plates reached ∼80% confluence. All 
bovine cells were derived from animals used in the food production industry, and so no 
institutional approvals were required. 
 
Cell encapsulation 
For 3D culture, MSCs (passage 2) or chondrocytes (passage 0 and passage 5) were 
encapsulated in 2% agarose microgels at a density of two million cells per ml. Molten 4% 
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w/v agarose (type VII, Sigma, 44 °C) was mixed 1:1 with cells suspended in media and 
pipetted into small drops in a well plate. Round coverslips were placed on top of the molten 
drops to spread the mixture before the gel solidified, resulting in the formation of uniform 
microgels that were 10–12 mm in diameter (depending on coverslip diameter) and 
∼400 μm thick. Coverslips were removed from the microgels before culture. Microgels 
were supplied with fresh media every 3 days and 24 h before collection. MSC microgels 
were maintained in a chemically defined media consisting of high-glucose DMEM 
supplemented with 1 × antibiotic–antimycotic, 40 ng ml−1 dexamethasone, 50 μg ml−1 
ascorbate 2-phosphate, 40 μgml−1 l-proline, 100 μg ml−1 sodium pyruvate, 1.25 mg ml−1 
bovine serum albumin, 5.35 μg ml−1 linoleic acid and 1 × insulin–transferrin–selenous acid 
premix (Corning CB-40350), either with or without 10 ng ml−1 TGFβ3 (R&D Systems) 
(Mauck et al., 2006). Chondrocyte microgels were cultured in basal media (high-glucose 
DMEM+10% FBS+1 × antibiotic–antimycotic) supplemented with 50 μg ml−1 ascorbate 2-
phosphate. At defined time points, gels were fixed for 30 min in paraformaldehyde (PFA) 
and stored in 70% ethanol at 4 °C. 
 
Cell viability in gels was measured using the LIVE/DEAD Cell Viability Assay Kit 
(Molecular Probes L-3224). A custom Matlab script quantified the number of live (calcein-
AM positive) and dead (ethidium-homodiner-1 positive) cells in three 4 × fields of view per 
microgel. To measure viability in conjunction with RNA FISH, a fixable, amine-binding 
green fluorescent dead cell stain (Molecular Probes L-23101) was employed. For fixable 
dead staining, microgels were washed with PBS, stained for 30 min in a 1:5,000 dilution 




Chondrogenic pellet culture and biochemical content 
Clonally derived passage 2 MSCs were formed into cell-rich pellets via centrifugation 
(200,000 cells per pellet) and cultured in chondrogenic induction media with TGFβ for 21 
days (Farrell et al., 2015). Pellets were papain digested and biochemically assayed for 
glycosaminoglycan and DNA content using 1,9-dimethylmethylene blue and Picogreen 
(Molecular Probes, Eugene, OR) assays, respectively (Farrell et al., 2015). 
 
Live cell imaging and tracking 
To quantify mRNA levels as a function of the time history of division, passage 2 MSCs 
were seeded into two-well LabTek chambered coverglass dishes (Fisher Scientific) and 
cultured in chondrogenic induction media with TGFβ for 4 days. Seeded cells were 
supplied with fresh media every 3 days and 24 h before fixation. Over the last 3 days of 
culture, live cells were imaged using a Nikon Ti-E microscope with a custom environmental 
chamber. Transmitted light images were automatically acquired every 30 min over a 
period of 70 h using a × 10 air objective over a 289-image grid in each well of the two-well 
coverglass. Cell division was tracked manually using ImageJ, and matched to the 
corresponding RNA FISH quantification that followed. 
 
RNA fluorescence in situ hybridization and imaging 
Single-molecule RNA FISH was performed on samples (Raj et al., 2008). Microgels and 
monolayer cells were fixed in PFA and permeabilized with 70% ethanol before in situ 
hybridization was performed using the specified pools of oligonucleotides. Monolayer and 
microgel samples were simultaneously co-stained with oligonucleotide probes for 
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osteopontin labelled with Cy3, LPL labelled with Alexa 594, aggrecan labelled with Atto 
647 N and GAPDH labelled with Atto700 (Stellaris oligonucleotides, Biosearch 
Technologies). See Supplementary Table 9 for a complete list of sequences of 
oligonucleotide probes used in this chapter 2. Subsequently, samples were washed with 
2 × saline sodium citrate buffer (SSC) with 10% formamide (Ambion), and then 2 × SSC 
supplemented with DAPI (Molecular Probes D3571) to stain the cell nuclei. Monolayer 
cells cultured in coverglass chambers were submerged in 2 × SSC for imaging. Microgels 
were mounted in 2 × SSC and compressed between a coverglass and slide for imaging. 
Cells in the microgel and small colonies were imaged using a Leica DMI600B automated 
widefield fluorescence microscope equipped with a × 100 Plan Apo objective, a Pixis 
1024BR cooled CCD (charge-coupled device) camera, a Prior Lumen 220 light source, 
and filter sets specific for each fluorophore. Images in each fluorescence channel were 
taken as a series of optical z-sections (0.5–0.7 microns per section) spanning the vertical 
extent of each cell. To prevent differences in viability between conditions from confounding 
interpretation of single-cell gene expression, the fixable dead cell stain was used to 
establish a GAPDH copy number of >10 mRNA as a threshold to identify live cells for 
inclusion in further analysis (Supplementary Fig. 1D). When this FISH analysis was 
applied to live-imaged cells, single plane scans were performed using a Nikon Ti-E 
microscope with a × 63 Plan Apo objective. 
 
Quantification of copy number from RNA FISH images 
On collecting images of RNA FISH samples, cell boundaries were manually identified and 
RNA spots were counted and localized using custom software written in MATLAB (Raj et 
al., 2008). For spot counting in FISH images from live cell tracking, each cell was tracked 
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through the acquired time series, and sister cells manually matched, with care taken to 
note the time since last division. 
 
Quantification of extracellular matrix deposition 
Extracellular aggrecan protein content was quantified by immunostaining. Briefly, after the 
final wash stages of the FISH protocol, samples were incubated with primary antibody 
(Abcam ab3778, 1:50 in PBS) at 4 °C overnight, washed for 30 min in PBS, incubated with 
Alexa 488 secondary antibody (Invitrogen, 1:200 in PBS) at room temperature for 1 h, 
washed with PBS for 30 min and then mounted for imaging. For immunofluorescence 
images, a scorer blinded to the RNA FISH images examined the DAPI, GFP (aggrecan 
core protein) and transmitted light images to classify cells with and without extracellular 
aggrecan core protein staining. 
 
Receiver operating characteristic curves were constructed and analysed using the pROC 
package in R (Robin et al., 2011). Matrix deposition (high versus low) was used as the 
binary outcome, and sensitivity and specificity were calculated for possible thresholds of 
RNA copy number, a linear combination of RNA counts and RNA ratios. To construct the 
linear combination, the data sets corresponding to each batch (Batch 1: Donors D-F, 
assayed for aggrecan, osteopontin, LPL, GAPDH; Batch 2: Donors X-Z, assayed for 
COMP, Sox9 and GAPDH) were randomly split in half to create training and test data sets 
to be used for model construction and evaluation, respectively. Logistic regression was 
performed using glm in R, and non-significant terms were dropped. For batch 1, the final 





the estimated probability of the i-th cell having high matrix staining, was a function of the 
cell's aggrecan and osteopontin expression. Aggrecan associated positively 
(βACAN=0.003, P<0.001), while osteopontin associated negatively (βOPN=−0.001, 
P=0.05); other markers were not significantly associated with matrix deposition. For batch 
2, the intercept was the only significant term and the model was not further analysed. 
Having established this model on the training data set, its predictive performance was 
evaluated by constructing an ROC curve of the model applied to the test data set. 
 
RNA sequencing 
Poly-adenylated RNA from passage 1 clonal MSCs populations were isolated from 
monolayer culture in basal media. The Qiagen miRNeasy kit was used for RNA isolation, 
the NEB Next Poly(A) mRNA Magnetic Isolation Module was used for selection of poly-
adenylated transcripts and NEB Next Ultra Library Preparation Kit for Illumina was used 
for library preparation. Each sample was sequenced with 50-bp single-end reads on an 
Illumina HiSeq and to a depth of 15–25 M reads. Reads were aligned to bosTau7 using 
STAR69. Reads per gene were quantified using HTSeq and a RefSeq bosTau7 from 
annotation release 103 (Anders et al., 2015; Dobin et al., 2013). FPKM (fragments per 
kilobase of transcript per million mapped reads) for each gene was calculated using R. 
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Cell volume and area measurements 
Chondrocyte area was measured in ImageJ by manually tracing images of phalloidin-
stained cells sparsely plated onto glass coverslips. Chondrocyte suspended cell volumes 
were computed from the cell radii measured by an automatic cell counter (Nexcelom 
Cellometer) for chondrocytes in solution during passaging (immediately following 
trypsinization). 
 
Alcian blue staining 
Microgels were removed from 70% ethanol and equilibrated in 3% acetic acid for 30 min 
at room temperature. Gels were then transferred to Alcian blue solution (pH 1.0, Rowley 
Biochemical) for 30 min, washed three times in acid alcohol (1% hydrochloric acid in 70% 
ethanol) for 30 min and then washed in PBS for 30 min before imaging. For macroscopic 
images, gels were photographed using a Ricoh photocopier and digital camera. For 
microscopic images, microgels were mounted in PBS and compressed between a 




To compare mean single-cell RNA counts, a generalized linear mixed model with a log-
link function and by-donor random intercepts was constructed. For MSC RNA counts, 
media condition, and culture duration (with interaction term) were considered fixed effects, 
and an additional by-donor random slope effect was associated with media (−TGFβ versus 
+TGFβ). For MSC RNA divergence, time-since-division was considered a fixed effect. For 
chondrocyte RNA counts during de-differentiation in monolayer, passage was considered 
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a fixed effect and was also associated with a by-donor random slope. For chondrocyte 
RNA counts during re-differentiation, passage and culture duration (with interaction term) 
were considered fixed effects, and an additional by-donor random slope effect was 
associated with passage. In each model, estimated means were compared using 
Satterthwaite-based t-distributions with simulated adjustment for multiple comparisons 
(SAS Studio 3.3). Pooled chondrocyte aggrecan/GAPDH expression data were compared 
using a one-way analysis of variance with Tukey's post hoc test. Chondrocyte area and 
volume data were pooled across donors and compared using a one-way analysis of 
variance with Tukey's post hoc tests. Sample size was chosen based on previous 
experience with these assays. Details of all statistical comparisons are provided in the 
Supplementary Tables.  
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Chapter 3 Methods 
Cell culture, splicing inhibition, and FKBP5 induction 
HeLa (kind gift of the lab of Dr. Phillip Sharp, MIT) and A549 (human lung carcinoma, 
A549, ATCC CCL-185) cells were cultured in DMEM (Gibco) supplemented with 1X 
antibiotics and 10% fetal bovine serum (FBS, Fisher). Splicing inhibition was 
accomplished by treating HeLa cells with 1uM Pladienolide B (Tocris Biosciences, 
6070500U) for 4 hours, as described by (Nojima et al., 2015). HeLa cells were then fixed 
and used for RNA FISH as described below. FKBP5 was induced by treating A549 cells 
with 25nM dexamethasone (Sigma, D2915) for the specified lengths of time. A549 cells 
were then fixed and used for RNA FISH as described below. 
 
RNA fluorescence in situ hybridization and expansion microscopy 
Single-molecule RNA FISH was performed on samples as described previously(Raj et 
al., 2006). Cells were fixed in formaldehyde and permeabilized with 70% ethanol before 
in situ hybridization was performed using the probes described. Samples were 
simultaneously co-stained with probes for the exon of gene of interest (labelled in cy3), 
two introns of the gene of interest (labelled in alexa594 or atto647N), and cyclin mRNA 
(labelled in either atto700 or atto647N) (Stellaris oligonucleotides, Biosearch 
Technologies). Samples were then washed with 2 X saline sodium citrate buffer (SSC) 
with 10% formamide (Ambion), and then 2XSSC supplemented with DAPI (Molecular 
Probes D3571) to stain the cell nuclei. Cells were submerged in 2XSSC with DAPI for 
imaging. For combined expansion microscopy and RNA FISH, expansion microscopy was 
performed as described by Chen et al. (Chen et al., 2016). Cells were fixed and 
permeabilized as described above, before a poly-acrylamide gel was polymerized on top 
 86 
of the sample for 1 hour at 37oC. Cells were digested with proteinase K overnight at room 
temperature, then RNA FISH was performed as described above. Samples were then 
expanded in nuclease free water for 2 hours at room temperature, then expanded for an 
additional 2 hours at room temperature in nuclease free water with DAPI. Samples were 
submerged in nuclease free water with DAPI for imaging. 
 
Immunofluorescence 
Staining for SC35 and polymerase II were performed with antibodies against SC35 
(abcam ab11826, 1:200) and phospho S2 polymerase II (Active Motif, 61083, 1:200), 
respectively. Briefly, staining was performed on cells fixed and permeabilized as described 
above for RNA FISH. Primary antibody hybridization was carried out in 1XPBS overnight 
at 4oC. Samples were then washed with 1XPBS and incubated with secondary antibody 
for 1 hour in 1XPBS at room temperature. Samples were then washed with 1XPBS and 
RNA FISH was performed as described above. 
 
Imaging 
Cells were imaged using a Leica DMI600B automated widefield fluorescence 
microscope equipped with a X100 Plan Apo objective, a Pixis 1024BR cooled CCD 
(charge-coupled device) camera, a Prior Lumen 220 light source, and filter sets specific 
for each fluorophore. Images in each fluorescence channel were taken as a series of 
optical z-sections (0.3 microns per section).  
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RNA FISH quantification 
RNA FISH was quantified as described previously (Raj et al., 2006). Briefly, cells were 
manually segmented, a gaussian filter was applied to all spots, signal was distinguished 
from noise through semi-automated thresholding, each called spot was further fit to a 
gaussian to get sub pixel resolution, and transcription sites were chosen based on a global 
brightness threshold (Supplementary Figure 5A). Data was processed to assess distances 
and graphed in R.  
 
4sU labeled chromatin-associated RNA sequencing and splicing index analysis.  
 
HeLa S3 cells (ATCC, CCL-2.2) were maintained in DMEM media containing 10% FBS, 
100 U/ml penicillin, and 100 μg/ml streptomycin to 75% confluency. Cells were labeled in 
media containing 500 μM 4-thiouridine (4sU, Sigma, T4509) for 7.5 minutes. Plates were 
washed twice with 1X PBS and cells were lifted by scraping. Labeled cells were collected 
by centrifugation at 500 g for 2 minutes. To purify chromatin associated RNA, steps 8-21 
were followed exactly as described in (Mayer and Churchman, 2016). In brief, nuclei were 
collected by lysing samples of 10M cells in 200 μl cytoplasmic lysis buffer (0.15% (vol/vol) 
NP-40 (Thermo Fisher Scientific, 28324), 10 mM Tris-HCl (pH 7.0), and 150 mM NaCl) for 
2 min, layering over a 500 μl sucrose cushion (10 mM Tris-HCl (pH 7.0), 150 mM NaCl, 
25% (wt/vol) sucrose), and centrifuging at 16,000 g for 10 minutes. The nuclei pellet was 
washed in 800 μl wash buffer (0.1% (vol/vol) Triton X-100, 1 mM EDTA, in 1X PBS) and 
collected by centrifuging at 1,150 g for 1 minute. Nuclei were resuspended in 200 μl 
glycerol buffer (20 mM Tris-HCl (pH 8.0), 75 mM NaCl, 0.5 mM EDTA, 50% (vol/vol) 
glycerol, 0.85 mM DTT), and mixed with 200 μl nuclei lysis buffer (1% (vol/vol) NP-40, 20 
mM HEPES (pH 7.5), 300 mM NaCl, 1 M urea, 0.2 mM EDTA, 1 mM DTT) by pulse vortex 
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and incubated on ice for 2 minutes. The chromatin pellet was collected by centrifugation 
at 18,500 g for 2 minutes and resuspended in 1X PBS. All steps were performed at 4°C 
and buffers were prepared with 25 μM α-amanitin (Sigma, A2263), 0.05U/μl SUPERase.In 
(ThermoFisher Scientific, AM2694), and protease inhibitor mix (Roche, 11873580001).  
Chromatin-associated RNA was extracted using Qiazol lysis reagent (Qiagen, 79306) 
following the manufacturer’s instructions. 50 μg RNA per reaction was subjected to 4sU 
purification as described in (Dölken et al., 2008; Schwalb et al., 2016). In brief, labeled 
RNA (1 μg / 10 μl) was incubated with 10% biotinylation buffer (100mM Tris pH 7.5, 10mM 
EDTA) and 20% EZ-Link Biotin-HPDP (1 mg/mL resuspended in DMF, Thermo Fisher 
Scientific, 21341) for 1.5 hours 24°C in the dark and 800 rpm to mix. RNA was purified by 
shaking the sample with a 1:1 volume of chloroform/isoamylacohol (24:1), separating 
using a phase-lock tube at 16,000 g for 5 min, and performing isopropanol precipitation. 
Biotinylated RNA was separated using the μMACS streptavidin kit (Miltenyi Biotec, 130-
074-101) by mixing with μMACS streptavidin beads at a 2:1 ratio by volume at 800 rpm 
and 24°C for 15 min. RNA-streptavidin beads mix was transferred to the μMACS column 
and washed with wash buffer (100 mM Tris pH 7.5, 10 mM EDTA, 1 M NaCl, 0.1% Tween 
20) at 65°C and room temperature 3 times each. Selected RNA was eluted off the magnet 
using the reducing agent, DTT (0.1M), and purified using the miRNeasy micro kit 
(Qiagen, 217084) with on-column DNase I treatment (Qiagen, 79254). For the poly(A) 
depleted sample, the RNA was first concentrated using the RNA Clean and Concentrator 
kit (ZymoResearch, R1015). 10 μL Oligo(dT) Dynabeads (ThermoFisher, 61002) were 
washed in 10 μL Binding Buffer (20mM Tris.HCl pH 7.5, 1M LiCl, and 2mM EDTA). The 
sample was mixed with 10 μl binding buffer, heated to 65°C for 2 min, moved to ice, and 
mixed with 1 μl SUPERase.In (ThermoFisher Scientific, AM2694). The sample and beads 
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were mixed thoroughly and annealed by rotating continuously on a mixer for 5 minutes at 
room temperature. Poly(A) RNAs were collected on a magnet while depleted supernatant 
was removed and purified using the RNA Clean and Concentrator kit (ZymoResearch, 
R1015). Illumina sequencing libraries were prepared using the Ovation Universal RNA-
seq System (NUGEN, 0343-32) with Universal Human rRNA strand selection reagent 
(NUGEN, S01859) following the manufacturer’s instructions.  
All samples were sequenced 2x80 on a NEXTseq 500 sequencer (Illumina, San Diego, 
CA, USA) in the Biopolymers Facility at Harvard Medical School. Paired-end reads were 
aligned to the ENSEMBLE GRCh38 (release-86) reference genome using STAR (v2.5.1a) 
(Dobin et al., 2013) with default parameters (except for readFilesCommand=cat, 
limitIObufferSize=200000000, limitBAMsortRAM=64000000000, 
outReadsUnmapped=Fastx, outSAMtype=BAM SortedByCoordinate, 
outSAMattributes=All, outFilterMultimapNmax=101, outSJfilterOverhangMin=3  1  1  1, 
outSJfilterDistToOtherSJmin=0  0   0   0, alignIntronMin=11, alignEndsType=EndToEnd). 
Splicing index calculations were determined by summing the number of spliced and 
unspliced read pairs that span exon junctions by at least 3 nucleotides and calculating the 
total spliced read pairs divided by the total unspliced read pairs for each gene; splicing 
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